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ABSTRACT 
CAPILLARY PERFUSION KINEMATICS IN  
LUNGS OF OXYGEN−TOLERANT RATS 
Madhavi Ramakrishna, B.E. 
Marquette University, 2009 
Motivation:  
Prolonged exposure to oxygen at high concentrations (hyperoxia), a common 
treatment for hypoxemia, is toxic to the lungs. Rats exposed to 85% O2 for 5-7 days 
develop tolerance to the otherwise lethal effects of 100% O2. Elucidating the factors that 
contribute to this tolerance could further our understanding of the mechanisms of lung O2 
toxicity. Since vascular remodeling involving loss of capillary volume and endothelial 
surface area has been reported in lungs from rats exposed to 85% O2 for 7 days, we were 
interested in evaluating the effect of this hyperoxia model on lung capillary perfusion 
kinematics. This information is needed for evaluating the effect of this hyperoxia model 
on the metabolic functions of the pulmonary capillary endothelium, a primary target of 
O2 toxicity. Thus, the objective was to evaluate the effect of this hyperoxia model on lung 
capillary mean transit time ( t c) and distribution of capillary transit times (hc(t)).  
 
Methods: 
Venous concentration versus time outflow curves of fluorescein isothiocyanate 
labeled dextran (FITC-dex), a vascular indicator, and coenzyme Q1 hydroquinone 
(CoQ1H2), a compound which rapidly equilibrates with lung tissue on passage through 
the lung, were measured following their bolus injections into the pulmonary artery of 
isolated lungs from rats exposed to either room air or 85% O2 for 7 days. A capillary 
surface area index was estimated by measuring the rate of hydrolysis of the angiotensin 
converting enzyme substrate N-[3-(2-Furyl) acryloyl]-Phe-Gly-Gly (FAPGG) on passage 
through each lung. The mean transit time and variance of the measured FITC-dex and 
CoQ1H2 curves were first determined and then used in a mathematical model to estimate 
t c and the relative dispersion (RDc) of hc(t).  
 
Results: 
FITC-dex and CoQ1H2 data revealed that hyperoxia decreased lung t c by 41% 
and increased RDc, a measure of the heterogeneity of hc(t), by 40%. FAPGG data 
revealed that hyperoxia decreased lung capillary surface area by 56%.   
 
Conclusion:  
This study demonstrates the utility of CoQ1H2 for evaluating the effect of 
hyperoxia on capillary perfusion kinematics in intact rat lungs. The results are important 
for subsequent evaluation of the effect of hyperoxia on the metabolic functions of the 
pulmonary capillary endothelium. 
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1. INTRODUCTION AND BACKGROUND 
1.1 Introduction 
 The most common initial treatment for hypoxemia in premature babies with 
respiratory distress syndrome, and adults with  pulmonary insufficiency (e.g., acute 
respiratory distress syndrome (ARDS), pneumonia), is oxygen therapy (normobaric 
hyperoxia) (Jackson 1985; Singh 2001). However, exposure to high O2 concentrations  
(> 60%) for prolonged periods has been found to be toxic, primarily to the lungs 
(Bhandari et al. 2006; Crapo and Tierney 1974; Fisher and Beers 2008; Frank et al. 1989; 
Valenca Sdos et al. 2007). Although the mechanisms leading up to lung O2 toxicity are 
not fully understood, there is ample evidence that the deleterious effects of high O2 are 
the result of increased formation of reactive oxygen species (ROS), such as superoxide 
and hydrogen peroxide, which at high concentrations are known to cause various 
cytotoxic effects (Fisher 1987; Freeman and Crapo 1982; Freeman, Topolosky, and 
Crapo 1982; Heffner and Repine 1989; Jamieson et al. 1986; Kwak, Kwak, and Gauda 
2006; Turrens et al. 1982).  
 Several animal models have been developed to investigate the underlying 
mechanisms of lung O2 toxicity because of the clinical relevance of hyperoxic exposure 
and its importance as a model of oxidant-induced acute lung injury (Crapo et al. 1980; 
Crapo and Tierney 1974; Freeman, Topolosky, and Crapo 1982; Matute-Bello, Frevert, 
and Martin 2008; Valenca Sdos et al. 2007; Ware 2000). The rat model of hyperoxic lung 
injury mimics several aspects of lung O2 toxicity observed clinically, and rats exposed to 
85% O2 for 5-7 days acquire tolerance to the otherwise lethal effects of exposure to 100% 
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O2 (Crapo 1975; Crapo et al. 1980; Evelson and Gonzalez-Flecha 2000; Hayatdavoudi et 
al. 1981; Johnson et al. 1998). This tolerance is not observed in other rodents, but a 
similar tolerance occurs in humans (Capellier et al. 1999; Crapo and Tierney 1974). 
Elucidating the underlying mechanisms of this tolerance could lead to the identification 
of therapeutic targets for protection from lung O2 toxicity and oxidant-induced acute lung 
injury.  
 Previous studies have demonstrated hyperoxia-induced changes in the activities of 
redox enzymes, predominantly in lung tissue homogenates, and have suggested that 
redox enzymes, among other factors, play a role in rat tolerance to 100% O2 following 
exposure to 85% O2 (Crapo et al. 1980; Crapo and Tierney 1974; Ho, Dey, and Crapo 
1996; Kimball et al. 1976). However, the results of these in vitro studies do not 
necessarily predict hyperoxia-induced changes in the activities of redox enzymes in an 
intact lung (Audi et al. 2005; Audi et al. Oxygen dependency of monoamine oxidase 
activity in the intact lung 2001). This is because potential changes in key aspects of the 
enzyme environment in an intact lung (e.g., competing redox enzymes, availability of 
electron donors, tissue perfusion) that may influence redox enzyme kinetics are not 
preserved in vitro (Audi et al. 2005). Thus, a hyperoxia-induced change in the activity of 
a redox enzyme measured in lung tissue homogenate may not be representative of the 
change in its activity in the intact lung (Audi et al. 2005; Audi et al. Oxygen dependency 
of monoamine oxidase activity in the intact lung 2001). Studies evaluating redox enzyme 
kinetics in the intact lung have lagged behind the tremendous advances of in vitro cell 
biology, in part, because of the functional complexity of the intact lung. 
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 Indicator dilution methods have been important research tools for evaluating 
metabolic functions within an organ of interest (Audi et al. 2003; Audi et al. Oxygen 
dependency of monoamine oxidase activity in the intact lung 2001; Bassingthwaighte 
1998; Dawson 2003; Schwab and Goresky 1996; Zierhut et al. 2007). These methods 
involve the bolus injection or finite pulse infusion of two or more indicators into the 
organ’s arterial inlet, followed by the measurement of concentrations of these indicators 
in the venous effluent as a function of time. The injected indicators usually include a 
vascular indicator plus a test indicator that is a substrate or ligand for the organ’s 
metabolic function(s) of interest. The interactions of the test indicator with these 
metabolic function(s) on passage though the organ, result in characteristic differences 
between the vascular and test indicator venous effluent concentration versus time curves 
(Audi et al. 1994; Audi et al. 1995).  
 The information content in the data resulting from indicator dilution methods can 
be complex, because, in addition to the targeted tissue metabolic processes, several other 
factors can influence the amount of indicator that is removed and/or modified on passage 
through the organ (Audi et al. 1998). These include organ perfusion kinematics (e.g., 
capillary mean transit time, distribution of capillary transit times), lung tissue accessible 
to the test indicator from the vascular space and reactions taking place in the blood (e.g., 
plasma-protein binding). Thus, for a given test indicator, a change in measured indicator 
dilution data could result from change in the activities of metabolic processes with which 
the test indicator interacts and/or changes in one or more of the above factors. Therefore, 
proper interpretation of indicator dilution data requires information about these factors, 
including organ perfusion kinematics, and the use of mathematical models that account 
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for all these factors (Audi et al. 2003; Audi et al. Oxygen dependency of monoamine 
oxidase activity in the intact lung 2001; Bassingthwaighte 1998; Dawson 2003; Schwab 
and Goresky 1996; Zierhut et al. 2007).  
 Audi et al. have used indicator dilution methods and mathematical modeling to 
evaluate the activities of redox enzymes in the isolated perfused rat lungs (Audi et al. 
2003; Audi et al. 2005; Audi et al. Pulmonary reduction of an intravascular redox 
polymer 2001; Audi et al. Oxygen dependency of monoamine oxidase activity in the 
intact lung 2001; Audi et al. 2000; Dawson et al. 2000). For instance, Audi et al. have 
demonstrated that the redox active quinone test indicator duroquinone (DQ) is reduced to 
durohydroquinone (DQH2) on passage through the pulmonary circulation in the isolated 
perfused rat lung, wherein DQH2 appears in the venous effluent. Inhibitor studies 
revealed that NAD(P)H: quinone oxidoreductase 1 (NQO1) is the dominant reductase 
involved in the reduction of DQ to DQH2, and that the capacity of the lung to reduce DQ 
to DQH2 is a measure of NQO1 activity in the intact lung (Audi et al. 2003). NQO1 is 
predominantly a cytoplasmic anti-oxidant enzyme that is induced in response to oxidative 
stress (Audi et al. 2003; Cadenas 1995; Merker et al. 2004). Rat exposure to 85% O2 for 
21 days, as a model of pulmonary oxidative stress, increased the capacity of the lung to 
reduce DQ to DQH2, as well as lung tissue NQO1 activity and protein levels (Audi et al. 
2005). 
 Recently, Audi et al. demonstrated the capacity of the rat lung to reduce the redox 
active quinone test indicator 2,3-dimethoxy-5-methyl-6-[3-methyl-2-butenyl]-1,4-
benzoquinone (coenzyme Q1; CoQ1) to its hydroquinone form (CoQ1H2), and to oxidize 
CoQ1H2 to CoQ1 on passage through the pulmonary circulation (Audi et al. 2008). CoQ1 
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is a homolog of ubiquinone which is the endogenous quinone electron carrier in the 
mitochondrial electron transport chain located at the inner mitochondrial membrane (Di 
Virgilio and Azzone 1982; Fato et al. 1996; Merker et al. 2007; Rich and Harper 1990). 
Moreover, ubiquinone participates in other redox functions, as an anti- and pro-oxidant 
substance (Chan et al. 2002). Inhibitor studies revealed that mitochondrial complex I and 
NQO1 are the dominant sites of CoQ1 reduction on passage through the lung, and that 
mitochondrial complex III is the dominant site of CoQ1H2 oxidation (Audi et al. 2008). 
Both complexes I and III are important sources of reactive oxygen species (ROS) (Audi 
et al. 2008). Audi et al. demonstrated that rat exposure to 85% O2 for 48 hrs decreased the 
overall capacity of the lung to reduce CoQ1 to CoQ1H2, predominantly due to ~47% 
decrease in the capacity of mitochondrial complex I mediated CoQ1 reduction. This 
hyperoxia-induced decrease in lung complex I activity is potentially important to lung O2 
toxicity since mitochondrial complex I is a major source of ROS (Brueckl et al. 2006; 
Turrens 2003). 
Preliminary indicator dilution studies in Dr. Audi’s laboratory have demonstrated 
that rat exposure to 85% O2 for 7 days, which confers tolerance to 100% O2, alters the 
capacity of the rat lung to metabolize various redox active test indicators, including 
CoQ1, DQ, DQH2 and CoQ1H2, on their passage through the pulmonary circulation. 
Quantitative interpretation of the resulting indicator dilution data in terms of the effect of 
hyperoxia on the lung activities of redox enzymes, including NQO1 and mitochondrial 
complexes I and III, requires information about the effect of hyperoxia on the other 
factors that could affect the redox metabolism of DQ and CoQ1 on passage through the 
pulmonary circulation, including lung capillary mean transit time ( t c) and the distribution 
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of capillary transit times (hc(t)) (Audi et al. 1998). This is important, especially, since the 
pulmonary capillary endothelium is a primary target of O2 toxicity, and since vascular 
remodeling involving loss of capillary volume and endothelial surface area has been 
reported for this hyperoxia model (Crapo et al. 1980). To the best of our knowledge, there 
is no known information about the effect of rat exposure to 85% O2 for 7 days on hc(t). 
Thus, the objective of this study was to evaluate the effect of rat exposure to hyperoxia 
(85% O2 for 7 days) on the lung capillary mean transit time and the distribution of 
capillary transit times. The 7-day exposure period was chosen since there are several 
existing studies that have investigated the effect of this hyperoxia model on lung cellular 
composition, capillary volume and capillary endothelial surface area (Crapo et al. 1980).  
 
1.2 Methods for measuring lung capillary volume, mean transit time and/or 
capillary transit time distribution 
 
Several methods have been used previously to estimate rat lung capillary volume, 
mean transit time and/or transit time distribution (Ahuja 2007; Audi et al. 1994; Clough et 
al. 1994; Clough et al. 1998; Clough, Linehan, and Dawson 1997; Presson et al. 1997; 
Randell, Mercer, and Young 1990; Sjostrom and Crapo 1983; Wagner et al. 1982; 
Wagner et al. 1986). What follows is a brief description of each of these methods, and 
their inherent strengths and limitations.  
Morphometric methods have been used to evaluate the rat lung capillary volume 
and endothelial surface area (Crapo et al. 1980; Randell, Mercer, and Young 1990; 
Sjostrom and Crapo 1983). Generally speaking, morphometric methods involve fixing the 
lung tissue by injecting a fixative into the pulmonary artery, following which the lung is 
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sectioned. Stereology is then used to estimate morphometric parameters such as capillary 
volume and capillary surface area. Using a morphometric approach, Crapo et al. 
demonstrated that, compared to room air rats, rats exposed to hyperoxia (85% O2 for 7 
days) showed a ~53% decrease in the pulmonary capillary lumen volume, and in turn the 
capillary mean transit time (Crapo et al. 1980). However, morphometric methods can be 
tedious and can lead to over-estimation of the lung capillary volume due to the effect of 
tissue fixation on the lung capillary transmural pressure (Audi et al. 1994; Audi et al. 
1995). Moreover, these methods cannot be used to measure the distribution of lung 
capillary transit times.  
Glenny et al. developed a method for measuring capillary flow distribution using 
fluorescent microspheres (Glenny, Bernard, and Robertson 2000). The method involves 
the injection of fluorescent microspheres into the lung. The lung is then cut into pieces 
and microsphere deposition is measured in each piece. Assuming that microsphere 
deposition is proportional to capillary blood flow distribution, an estimate of capillary 
blood flow distribution can be obtained. Based on certain assumptions about the 
relationship between capillary flow distribution and transit time distribution, the capillary 
transit time distribution can then be estimated (Audi et al. 1998; King, Raymond, and 
Bassingthwaighte 1996). Glenny et al. used fluorescent microspheres in rats to determine 
the coefficient of variation of lung microsphere deposition, which is a measure of the 
heterogeneity of capillary flow distribution, at varying sampling volumes. They found 
that the coefficient of variation increased with decreasing sampling volumes down to the 
acinar level (Glenny, Bernard, and Robertson 2000). Thus, their study indicated the 
presence of capillary perfusion heterogeneity in the rat lung and also showed that it 
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increased continuously as progressively smaller lung regions were examined. Although 
this method provides spatial information about capillary blood flow distribution, it is 
destructive and the results are dependent on sampling volume. Moreover, it does not 
provide an estimate of the lung capillary mean transit time.  
Wagner et al. introduced a method for measuring capillary mean transit time and 
transit time distribution on the lung surface using fluorescence microscopy (Wagner et al. 
1982; Wagner et al. 1986). The method involves the injection of a fluorescent dye into 
the lobar artery and observing its passage through the pleural capillaries using in vivo 
microscopy. Presson et al. used a similar approach to measure the capillary mean transit 
time and the transit time distribution in rat lung subpleural capillaries by direct video-
microscopic recording of a fluorescent dye on its passage through the rat subpleural 
microcirculation (Presson et al. 1997). They selected a microscopic field that contained a 
single arteriole and a single venule of equal or smaller diameter for their measurements. 
This method relies on the assumption that the subpleural capillary network adequately 
represents the entire pulmonary capillary network. However, there are morphometric 
differences between subpleural and intrapulmonary capillary beds (Guntheroth, Luchtel, 
and Kawabori 1982; Miller 1947), which suggest that their estimates may not be 
representative of whole lung hc(t), although Presson et al. suggested that these differences 
might not be significant for the rat lung (Presson et al. 1997).  
Clough et al. developed an X-ray microfocal angiography method for estimating 
hc(t) in an isolated perfused dog lung lobe (Clough, Linehan, and Dawson 1997). The 
method involves imaging the passage of a bolus of radiopaque contrast through the lung 
vasculature using microfocal X-ray angiography. Time-absorbance curves at the inlet to 
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the lobar artery, outlet of the lobar vein, and microvasculature are acquired from the 
images by positioning regions-of-interest (ROIs) over the acquired images. The overall 
dispersion of the bolus within the lung lobe is then estimated from the differences in the 
first and second moments, namely the mean transit time and variance, respectively, of the 
inlet and the outlet time-absorbance curves. The lobar capillary transit time distribution is 
estimated by model-based deconvolution of the lobar artery inlet absorbance curve and 
the microvascular ROI absorbance curve. Ahuja (Ahuja 2007) used this method to 
measure the capillary transit time distribution in lung lobes from normal and hyperoxic 
(85% O2 for 14 days) rats. The results of her study showed that exposure of rats to 85% 
O2 for 14 days decreased lobar capillary volume by ~37% with no significant effect on 
the heterogeneity of lobar capillary transit time distribution (Ahuja 2007). One of the 
problems encountered by Ahuja was that she could not measure the capillary transit time 
distribution for the entire lung due to the confounding effects of other pre-lobar vessels in 
the background. Moreover, owing to the relatively short lengths of the rat lobar artery and 
lobar vein, use of the microfocal angiography approach in rat lung lobes was found to be 
sensitive to the placement of the lobar arterial and venous cannulae (Ahuja 2007). 
Goresky proposed an indicator dilution method called the ‘linear superposition 
method’ for estimating the capillary volume and transit time distribution (Goresky 1963). 
The method involves the arterial bolus injection of a vascular indicator and a flow-limited 
indicator, and the simultaneous measurement of their concentrations in the venous 
effluent as a function of time. Vascular indicators are confined to the vascular bed on 
passage through the organ. A flow-limited indicator is a compound that rapidly 
equilibrates between blood and tissue on passage through an organ’s capillary or 
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microvascular region (Audi et al. 1994; Audi et al. 1995; Goresky 1963). The capillary 
wall presents no barrier to its diffusion and flow is the only factor that limits the 
exchange of a flow-limited indicator between blood and tissue. Under the assumption that 
no dispersion occurs outside the capillary bed, Goresky showed that the flow-limited 
indicator venous effluent concentration versus time outflow curve (CF(t)) is a scaled 
version of the vascular indicator outflow curve (CR(t)). The scaling process requires two 
parameters λ and t n, where λ is the ratio of the flow-limited indicator extravascular 
volume to the capillary volume, and t n is the transit time through the organ’s conducting 
vessels (arteries and veins), which is assumed to be the same for the vascular and flow-
limited indicators. The scaling process involves the following sequence of steps: a) 
shifting the time axis of CF(t) backward by t n, b) scaling the concentration and shifted 
time axes of CF(t) by (1+ λ) and 1/(1+ λ), respectively, c) shifting the time axis of the 
scaled CF(t) forward by t n
  
(Audi 1998). The linear superposition method involves 
finding the values of λ and t n that minimize the sum of squared differences between 
CR(t) and the scaled CF(t) (Audi et al. 1995). Audi et al. utilized this approach to estimate 
the capillary transit time distribution in the isolated perfused rabbit lung with either 3H-
alfentanil or 14C- diazepam as the flow-limited indicator (Audi et al. 1995). 
Audi et al. developed  an indicator dilution (MID) method for estimating the capillary 
transit time distribution in an intact lung (Audi et al. 1994; Audi et al. 1995; Audi 1998), 
which relaxes the Goresky assumption of no vascular dispersion outside the capillary 
bed. The method is based on the following algebraic equations that relate the mean transit 
time (first moment; t), the variance (second central moment; σ2), and the skewness (third 
central moment; m3) of the concentration versus time outflow curves of a vascular 
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(1.2a) 
indicator (CR(t)) and a flow-limited indicator (CF(t)), following their arterial bolus 
injection, to those of the capillary transit time distribution hc(t).  
 
σF
2
– σR
2
= 1 + t e
t c
2
– 1 σc2            (1.1a) 
 
          mF
3
– mR
3
= 1 + t e
t c
3
– 1 mc3                           (1.1b) 
 
where the subscripts R, F and c refer to CR(t), CF(t), and hc(t) respectively. The 
extravascular mean residence time for the flow-limited indicator is given by 
 t   t  t 
Figure 1.1 (panel a.) shows the concentration versus time outflow curves of the vascular 
indicator fluorescein isothiocyanate dextran (FITC-dex) and the lipophilic amines test 
indicators 3H-alfentanil and 14C-diazepam following their arterial bolus injection into the 
pulmonary artery of an isolated perfused rat lung. These test indicators behave as flow-
limited indicators on passage through lungs from rats exposed to room air (panel a) (Audi 
et al. 2003; Audi et al. 1995). For each of these outflow curves, C(t), the shape of the 
curve can be described by its mean transit time (first moment; t), variance (second central 
moment; σ2), and skewness (third central moment; m3), which can be determined using 
the following equations:  
t = 	 t C
tdt∞0	 C
tdt∞
0
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σ  	 
t  t C
t dt	 C
t dt   
 
 
                                         m  	 
t  t C
t dt	 C
t dt   
 
The mean transit time is a measure of the average time the indicator spends in the 
organ, the variance is a measure of the distribution of C(t) about the mean transit time, 
and the skewness is a measure of the asymmetry of the distribution of C(t) around the 
mean. Estimation of the first three moments of hc(t) using Equations (1.1a-b) requires 
knowledge of the first three moments of the concentration versus time outflow curves of 
a vascular indicator CR(t) and at least two flow-limited indicators CF(t) with sufficiently 
different t e on passage through the lung (Audi et al. 1994; Audi et al. 1995).  
Audi et al. applied this MID method first in isolated perfused dog lung lobes 
using 14C-diazepam as the flow-limited indicator. Since diazepam participates in rapidly 
equilibrating interactions with perfusate albumin, the tissue-to-plasma partition 
coefficient of 14C-diazepam, and hence its apparent t e, could be adjusted by altering the 
perfusate albumin concentration. Thus, by making two injections of 14C-diazepam, each 
at a different perfusate albumin concentration, data equivalent to making one injection 
with two different flow-limited indicators having different t e values were obtained (Audi 
et al. 1994). Subsequently, Audi et al. used the method in isolated rabbit lungs, with 
lipophilic amines, 3H-alfentanil and 14C- diazepam, as the two flow-limited indicators 
with different t e values (Audi et al. 2003; Audi et al. 1995). 
 
(1.2b) 
 (1.2c) 
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Figure 1.1: Venous effluent FITC-dex, 3H-alfentanil and 14C-diazepam concentration 
versus time curves in a normoxic lung (panel a.) and a hyperoxic lung (85% O2 for 6 
days, panel b.). The recoveries for 3H-alfentanil and 14C-diazepam in the venous effluent 
were ~100% for the normoxic lung, and ~85% and ~65% for the hyperoxic lung, 
respectively. 
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Using 3H-alfentanil and 14C- diazepam, Audi et al. estimated the pulmonary 
capillary transit time distribution in normoxic isolated perfused rat lungs (Audi et al. 
2003). They estimated a vascular volume of ~0.85 ± 0.06 (SE) ml, a capillary volume of 
~0.47 ± 0.02 ml and a capillary relative dispersion (RDc) of ~0.91 ± 0.03, where RDc is a 
non-dimensional measure of the heterogeneity of hc(t). The use of this approach for 
evaluating the effect of rat exposure to hyperoxia (85% O2 for 7 days) on lung capillary 
mean transit time and hc(t) requires that alfentanil and diazepam exhibit flow-limited 
behavior on passage through the pulmonary circulation of lungs from rats exposed to this 
hyperoxia model. Upon subsequent examination, results (unpublished) revealed that 
neither alfentanil nor diazepam exhibit flow-limited behavior in lungs from rats exposed 
to 85% O2 for 6 to 8 days. Figure 1.1 shows the concentration versus time outflow curves 
of 3H-alfentanil, 14C- diazepam, and the vascular indicator FITC-dex following the bolus 
injection of these indicators into the arterial inlets of an isolated perfused lung from a 
normoxic rat (panel a.), and from a rat exposed to 85% O2 for 6 days (panel b.). For the 
normoxic lung, the recoveries of the injected alfentanil and diazepam in the venous 
effluent were not significantly different from 100%. However, for the hyperoxic lung, 
only 65% of the injected diazepam and 85% of the injected alfentanil were recovered in 
the venous effluent. This suggests that both alfentanil and diazepam participate in slowly 
dissociating interactions on passage through the hyperoxic lung and hence do not behave 
as flow-limited indicators (Audi et al. 2002). 
Recently, Audi et al. demonstrated that the reduced form (CoQ1H2) of the quinone 
compound coenzyme Q1 behaves as a flow-limited indicator on passage through the 
isolated perfused lungs of rats exposed to room air or to 85% O2 for 48 hrs (Audi et al. 
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2008). This suggests using CoQ1H2 as one of the two flow-limited indicators for 
evaluating hc(t) in hyperoxic rat lungs using the method represented by Equations (1.1a-
b). As an alternative to searching for a second flow-limited indicator with an 
extravascular mean residence time ( t e) different from that of CoQ1H2, one could exploit 
the fact that CoQ1H2 binds to perfusate albumin in a rapidly equilibrating manner (Audi 
et al. 2008). Audi et al. derived the following relationship between the perfusate albumin 
concentration and the extravascular mean residence time of a flow-limited indicator that 
rapidly interacts with perfusate protein on passage through the lung.  
 
t = M QF 1  PK  
               
 
where, M is the tissue-to-plasma partition coefficient of the flow-limited indicator, K is 
the indicator-plasma protein binding equilibrium dissociation constant, F is the perfusate 
flow, Qt is the extravascular tissue volume accessible by the flow-limited indicator, and 
[P] is the perfusate albumin concentration (Audi et al. 1994; Audi et al. 1995). 
Equation 1.3 suggests that t e is inversely proportional to perfusate albumin 
concentration [P]. Thus, the value of
 
t e for CoQ1H2 on passage through the lung could be 
manipulated by altering the perfusate albumin concentration. Hence, bolus injections of 
CoQ1H2 at different perfusate albumin concentrations would provide data equivalent to 
bolus injections of multiple flow-limited indicators with different t e values. Hence, the 
specific aims of this study are to: 
 
 (1.3) 
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1) evaluate the effect of manipulating perfusate albumin concentration on CoQ1H2 
extravascular mean residence time ( t e) during its passage through the isolated 
perfused rat lung, and to select the albumin concentrations that result in CoQ1H2 
curves with sufficiently different t e values, 
 
2) utilize the MID method developed by Audi et al., with CoQ1H2 at different 
perfusate albumin concentrations as the flow-limited indicators, to evaluate the 
effect of rat exposure to hyperoxia (85% O2 for 7 days) on rat lung capillary mean 
transit time and transit time distribution. 
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2. EXPERIMENTAL METHODS 
2.1  Materials 
Coenzyme Q1 (CoQ1) and other chemicals, unless noted, were purchased from 
Sigma (St. Louis, MO). CoQ1H2 was prepared by reduction of CoQ1 with potassium 
borohydride (KBH4) as previously described (Audi et al. 2005). Bovine serum albumin 
(BSA) was purchased from Serologicals Inc. (Gaithersburg, MD).  
 
2.2  Oxygen exposure 
For normoxic lung studies, Sprague-Dawley rats (~300 g; Charles River) were 
exposed to room air with free access to food and water. For the hyperoxic lung studies, 
age matched rats were housed in a Plexiglas chamber (13W x 23L x 12H inches) (Figure 
2.1) maintained at ~85% O2, balance N2, for 7 days with free access to food and water as 
previously described (Audi et al. 2005). The total gas flow was ~3.5 liters/min and the 
chamber CO2 was maintained at < 0.5 %. The temperature within the chamber was 
maintained at ~21oC using a custom built cooling system. The chamber was opened 
every other day for ~15 min to clean the cage, weigh the animals, and replace food, 
water, and CO2 absorbent. The protocol was approved by the Institutional Animal Care 
and Use Committees of the Veterans Affairs Medical Center and Marquette University 
(Milwaukee, WI). A total of 9 normoxic rats and 5 hyperoxic rats were studied. 
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Figure 2.1: Sprague-Dawley rats in the Plexiglas exposure chamber. Flow meters were 
used to regulate the inflow of air and O2 and to maintain the chamber O2 at 85%. 
 
2.3 Isolated perfused lung preparation 
The isolated perfused rat lung preparation has been previously described (Audi et 
al. 2005; Audi et al. 2008). Each rat was anesthetized with pentobarbital sodium (40 
mg/kg body wt. i.p.). The trachea was clamped, the chest was opened, and heparin (0.7 
IU/g body wt.) was injected into the right ventricle. The pulmonary artery and the trachea 
were cannulated, and the pulmonary venous outflow was accessed via a cannula in the 
left atrium. The lung was removed from the chest and attached to a ventilation-perfusion 
system. The control perfusate contained in mM 4.7 KCl, 2.51 CaCl2, 1.19 MgSO4, 2.5 
KH2PO4, 118 NaCl, 25 NaHCO3, 5.5 glucose, and 5% BSA (Audi et al. 2003; Audi et al. 
2005; Audi et al. 2008). The single pass perfusion system was primed with the control 
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perfusate maintained at 37oC and equilibrated with 15% O2, 6% CO2, balance N2, 
resulting in perfusate PO2, PCO2 and pH of ~105 Torr, 40 Torr, and 7.4, respectively. An 
injection loop was included in the arterial line to allow the introduction of a ~0.1 ml 
bolus into the arterial inflow without altering the flow or perfusion pressure (Audi et al. 
2003; Audi et al. 2005; Audi et al. 2008). Initially, control perfusate was pumped through 
the lung until the lung was evenly blanched and the venous effluent was clear of blood, as 
determined by visual inspection. The lung was ventilated (40 breaths/min) at end-
inspiratory and end-expiratory pressures of 6 and 3 mmHg, respectively, with the above 
gas mixture. The pulmonary arterial pressure was referenced to atmospheric pressure at 
the level of the left atrium and monitored continuously during the course of the 
experiments. The venous outflow was referenced to atmospheric pressure. At the end of 
each experiment, the lung was weighed, and then dried (60oC) to a constant weight for 
the determination of lung dry weight. 
 
2.4  Experimental protocols 
Table 2.1 shows a schematic diagram of the experimental protocol described 
below. An index of perfused capillary surface area was estimated as previously described 
(Audi et al. 2005; Audi et al. 2008). Briefly, a 150 µM 20-second pulse infusion of the 
ACE substrate N-[3-(2-Furyl) acryloyl]-Phe-Gly-Gly (FAPGG) was introduced into the 
lung with the flow set at 30 ml/min. Two venous effluent samples (~1.0 ml each) were 
collected between 15 and 20 seconds after the start of the infusion (Audi et al. 2005; Audi 
et al. 2008). The permeability-surface area product (PS, ml/min) for FAPGG, which is a 
measure of the rate of ACE mediated FAPGG hydrolysis, was determined from the 
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FAPGG concentrations measured in the venous effluent samples as previously described 
(Audi et al. 2005; Audi et al. 2008): 
 
PS = – F ln 1 – E       (2.1) 
 
 
where E = steady state extraction ratio = 1 – [FAPGG]o[FAPGG] i
;   
 
[FAPGG]i is the infused arterial FAPGG concentration; [FAPGG]o is the steady state 
venous effluent FAPGG concentration calculated as the average [FAPGG] in the 
collected venous effluent samples, and F is the perfusate flow. The PS product is 
considered here as an index of perfused capillary surface area (Audi et al. 2005; Audi et 
al. 2008). 
 
Table 2.1: Schematic diagram of the experimental protocol 
 
Treatment  Potassium Cyanide (2 mM)  
Flow 30 ml/min 10 ml/min 30 ml/min 
Pefusate 5% BSA 5%BSA 3% BSA 10% BSA 5% BSA 
Indicator 
dilution 
experiment 
FAPGG 
pulse 
infusion 
FITC-dex 
and CoQ1H2 
bolus 
injections 
CoQ1H2 
bolus 
injection 
CoQ1H2 
bolus 
injection 
FAPGG 
pulse 
infusion 
 
     
Time 
  
For each lung, the FAPGG pulse infusion was carried out at the beginning and at 
the end of the CoQ1H2 and FITC-dex bolus injection protocol described below to 
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evaluate the stability of the lung by this measure over the time course of the experiment. 
For both FAPGG pulse infusions the lung was perfused with control perfusate. 
 
 
 
 
 
 
 
 
  
 
 
 
Figure 2.2: Schematic diagram of the rat lung ventilation-perfusion system. Arrows 
indicate the direction of perfusate flow. 
 
 
 After the first FAPGG pulse infusion, each lung was perfused with control 
perfusate containing 2 mM potassium cyanide (KCN) for 5 min at 10 ml/min to inhibit 
mitochondrial complex III, which is the main site of CoQ1H2 oxidation on passage 
through the rat lung (Audi et al. 2008). The respirator was then stopped at end expiration 
and a 0.1 ml bolus of control perfusate containing 2 mM KCN and either 35 µM FITC-
dex (vascular indicator) or 1200 µM CoQ1H2 (flow-limited indicator) was injected into 
the pulmonary arterial inflow tubing. Simultaneous to each bolus injection, the venous 
15% O2, 6% CO2 
Pulmonary 
Artery 
Pulmonary 
Vein 
 Masterflex  
Roller Pump                           
(Flow-rate: 10ml/min) 
Perfusate with 3%, 
5% or 10% BSA 
concentration 
Rat lung 
Bolus of 
FITC - dex 
or CoQ1H2 
FITC - dex or CoQ1H2 
venous effluent samples 
collected using a fraction 
collector 
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effluent was diverted into a modified Gilson Escargot fraction collector for continuous 
collection (Audi et al. 2003; Audi et al. 2005; Audi et al. 2008). For the FITC-dex bolus 
injection, sixty samples (0.15 ml each) were collected at a sampling interval of 0.9 sec at 
a flow of 10 ml/min. For the CoQ1H2 injection, sixty samples (0.3 ml each) were 
collected at a sampling interval of 1.8 sec at a flow of 10 ml/min. Two reasons for the 
difference in sampling intervals (volumes) of FITC-dex and CoQ1H2 are:  1) the 
minimum CoQ1H2  sampling volume (and hence the sampling time) is limited by the 
sensitivity of the assay used to measure the concentration of CoQ1H2 in the venous 
effluent samples; 2) the rate of change in the concentration of FITC-dex in the venous 
effluent is greater than that for CoQ1H2, which necessitates a smaller sampling interval 
for FITC-dex, especially around the peak of its concentration versus time outflow curve. 
 To determine the influence of perfusate albumin binding of CoQ1H2 on its 
pulmonary disposition, we examined the influence of perfusate BSA concentration on the 
concentration versus time outflow curve of CoQ1H2 following its arterial bolus injection. 
After the first two bolus injections with perfusate containing 5% BSA (control perfusate), 
the perfusate reservoir was refilled with an appropriate volume of fresh perfusate 
containing 3% BSA and 2 mM KCN. This was followed by another 0.1 ml bolus 
injection of 3% BSA perfusate containing KCN and CoQ1H2, and a sampling of the 
venous effluent as described above. Following this, another CoQ1H2 bolus injection was 
carried out after adjusting the reservoir perfusate BSA concentration to 10% in the 
presence of KCN. The choice of 3% and 10% BSA concentrations were based on 
Equation 1.3, which predicts a ~50%  increase and decrease in the t e of CoQ1H2 
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compared to the control perfusate (5% BSA) at perfusate BSA’s of 3% and 10%, 
respectively. 
At the end of the bolus injection and pulse infusion protocols, the lung was 
removed from the perfusion system, the arterial and venous cannulae were connected, 
and the reservoir was refilled with control perfusate. This was followed by an FITC-dex 
(35 µM) bolus injection at a pefusate flow of 10 ml/min. Thirty samples (0.15 ml each) 
were collected at a sampling interval of 0.9 sec. From this data, we determined the tubing 
transit time of the perfusion system and the bolus dispersion outside the lung. 
 
2.5 Determination of CoQ1H2 and FITC-dex in venous effluent samples 
The concentrations of CoQ1H2 in the venous effluent samples were determined as 
previously described (Audi et al. 2003; Audi et al. 2005; Audi et al. 2008). The venous 
effluent samples were first centrifuged (1 min at 5,600 g). For each sample, 100 µl of 
supernatant was then added to a centrifuge tube containing 10 µl potassium ferricyanide 
(12.1 mM in deionized H2O) to oxidize any CoQ1H2 to CoQ1. Cold absolute ethanol 
(~0.6 ml) was added and the tube was mixed on a vortex mixer followed by 
centrifugation at 9,300 g for 5 min at 4°C. A perfusate sample that had passed through 
the lungs, but contained no CoQ1H2, was treated in the same manner to be used as the 
blank for absorbance measurements. Sample concentration of CoQ1, in µM, was 
calculated from the absorbance (Abs) value (Beckman DU 7400 spectrophotometer) at 
275 nm of the fully oxidized supernatant in the tube using a molar extinction coefficient 
of 14.30 mM-1 cm-1 as follows:  
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  [CoQ1] = Abs0.0143      (2.1) 
 
where [CoQ1] is the concentration of CoQ1 in the samples, which is also the sample 
concentration of CoQ1H2 prior to the addition of potassium ferricyanide to oxidize 
CoQ1H2 to CoQ1. Thus, for a given venous sample, [CoQ1H2] is given by Equation (2.2): 
 
                           [CoQ1H2] = Abs0.0143           (2.2) 
 
The concentration of FITC-dex  in each venous effluent sample was determined 
from the sample absorbance at 495 nm using a molar extinction coefficient of 93.5  
mM-1 cm-1 (Audi et al. 2003; Audi et al. 2005; Audi et al. 2008).  
The respective calculated recoveries for FITC-dex and CoQ1H2 in the venous 
effluent samples following their arterial bolus injections were 93.25 ± 5.8 (SE) % and 
101.27 ± 1.1 % for normoxic lungs, and 106.22 ± 5.2 % and 109.37 ± 3.4 % for 
hyperoxic lungs, respectively, none of which were significantly different from 100%.  
 
2.6 Statistical analysis 
Statistical comparisons were carried out using an unpaired t-test or ANOVA, 
followed by Tukey’s test, with P < 0.05 as the criterion for statistical significance.  
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3. EXPERIMENTAL RESULTS 
 
3.1 Physiological parameters 
Figure 3.1 shows the normalized body weights of rats exposed to 85% O2 at 
different time points during the 7-day exposure period. For the first 48 hrs of hyperoxic 
exposure, rats gained weight. Between days 2 and 6, rat body weights decreased steadily. 
However, by day 7, the rats stopped losing body weight. Over the 7-day exposure period, 
rats lost ~10 % of their pre-exposure body weights (Figure 3.1).   
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Figure 3.1: Rat body weights normalized to pre-exposure body weights at different time 
points during the 7-day exposure period. Values are mean ± SE (n = 5). * indicates values 
that are significantly different from the body weight on day 0 (t-test; p < 0.05).  
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Rat exposure to hyperoxia significantly increased lung wet and dry weights, with 
no significant effect on lung wet/dry weight ratios or lung perfusion pressure at 10 
ml/min or 30 ml/min as compared to normoxic lungs (Table 3.1). The lung wet weights 
of hyperoxic rats measured in the present study are consistent with those reported by 
Crapo et al. (2.29 ± 0.44 (SD) g for ~290 g rats) for the same hyperoxia model (Crapo et 
al. 1980). The lack of a significant difference in wet/dry weight ratio between normoxic 
and hyperoxic lungs suggests that the increase in wet weights of hyperoxic lungs was due 
to infiltration of cells rather than due to edema (Crapo et al. 1980). Changes in perfusate 
BSA %  had no significant effect on lung perfusion pressure for normoxic and hyperoxic 
lungs (data not shown).  
Exposure to hyperoxia increased the circulatory blood hematocrit (Table 3.1). 
This increase is consistent with that observed by Crapo et al. after 7 days of exposure to 
85% O2, which could be in part due to dehydration (Crapo et al. 1980).  
Table 3.1: Body weights, lung wet weights, dry weights and wet/dry weight ratios, 
circulatory blood hematocrit (Hct) and lung perfusion pressures (Pa) for normoxic and 
hyperoxic rats. 
 
 
n = 9 and 5 for normoxic and hyperoxic (85% O2 for 7 days) rats, respectively. Values 
are mean ± SE. * indicates values that are significantly different between normoxic and 
hyperoxic lungs (t-test; p < 0.05).  
 
Body 
wt (g) 
Wet 
wt (g) 
Dry 
wt (g) 
 
Wet/dry 
wt 
 
 
Hct 
(%) 
 
Pa (Torr) 
10ml/min 
 
Pa (Torr) 
30 ml/min 
 
Normoxic 
lungs 
 
292  
± 9 
1.20 ± 
0.07 
0.21 ± 
0.01           
5.76 ± 
0.16 
42.9 ± 
0.7 5.0 ± 0.3 9.9 ± 0.5 
 
Hyperoxic 
lungs 
 
283 ± 
5 
2.40 ± 
0.21* 
0.41 ± 
0.04* 
5.87 ± 
0.09 
49.42 ± 
0.7* 5.6 ± 0.3 10.0 ± 0.5 
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3.2 Lung ACE activity and perfused capillary surface area 
The permeability-surface area product (PS, ml/min) for FAPGG, which is a 
measure of the rate of ACE mediated FAPGG hydrolysis, is considered here as an index 
of perfused capillary surface area (Audi et al. 2005; Audi et al. 2008). Exposure to 
hyperoxia decreased PS (ml/min) on average by ~58 % (Table 3.2). The PS values 
obtained from FAPGG pulse infusions carried out at the beginning or at the end of a 
given experimental protocol were not significantly different, indicating that perfusion 
and/or multiple bolus injections of CoQ1H2 and FITC-dex did not have significant 
irreversible effects on lung capillary endothelial surface area and/or angiotensin 
converting enzyme (ACE) activity. Therefore, by these measures, the lungs were stable 
over the time course of the experimental bolus injection protocol. 
 
Table 3.2: Angiotensin converting enzyme (ACE) activity in normoxic and hyperoxic 
lungs 
 
 PS (ml/min) 
(Start) 
PS (ml/min) 
(End) 
Normoxic lungs 17.5 ± 1.0 15.7 ± 1.2 
Hyperoxic lungs 7.7 ± 0.5* 6.4 ± 0.2* 
 
PS (permeability surface area product), a measure of the rate of ACE mediated FAPGG 
hydrolysis and an index of perfused capillary surface area, evaluated at the start and the 
end of the bolus injection experiments for normoxic (n = 9) and hyperoxic (n = 5) rat 
lungs. Values are mean ± SE. * indicates values that are significantly different between 
normoxic and hyperoxic lungs (t-test; p < 0.05). 
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3.3 FITC-dex and CoQ1H2 bolus injections 
Figure 3.2 shows an example of venous effluent concentration versus time 
curves of FITC-dex and CoQ1H2, obtained after bolus injections of FITC-dex and 
CoQ1H2 into the arterial inlet of a normoxic lung (panel a.) and a hyperoxic lung (panel 
b.) perfused with perfusate containing three different BSA concentrations. The FITC-
dex concentration versus time curves indicate what the effluent CoQ1H2 curves would 
have looked like, had the CoQ1H2 not interacted with the lung tissue as it passed 
through the pulmonary vessels (the effect of convection alone). For the normoxic lung 
(panel a.), the CoQ1H2 curves are shifted to the right (indicating longer transit times on 
account of CoQ1H2 accessing lung tissue volume) and more dispersed (lower peaks and 
longer tails) relative to the FITC-dex curve, consistent with the flow-limited behavior of 
CoQ1H2 in the lung tissue (Audi et al. 2003; Audi et al. 2005). Moreover, the CoQ1H2 
curves show a progressive increase in the transit time (first moment) of CoQ1H2 as 
perfusate BSA concentration decreased. For the hyperoxic lung (panel b.), the FITC-dex 
curve has a higher peak than that for the normoxic lung, consistent with a decrease in 
lung vascular volume. The CoQ1H2 curves are also more dispersed than the FITC-dex 
curve, and the transit time of CoQ1H2 is inversely proportional to perfusate BSA 
concentration. However, for the hyperoxic lung, the peaks of the CoQ1H2 curves are 
less shifted to the right of the peak of the FITC-dex curve as compared to the normoxic 
lung. 
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Figure 3.2: Venous effluent FITC-dex and CoQ1H2 normalized concentration (as a 
fraction of the injected amount per milliliter of effluent perfusate) vs. time data following 
the bolus injection of the indicators upstream from the pulmonary artery of a normoxic 
(panel a.) and a hyperoxic (panel b.) lung perfused at three different perfusate % BSA 
concentrations. Lungs were treated with potassium cyanide (KCN) prior to bolus 
injection to inhibit complex III mediated CoQ1H2 oxidation on its passage through the 
lung. For the FITC-dex curve, the perfusate BSA concentration was 5%. 
30 
 
   
4. DATA ANALYSIS 
 
4.1 Estimation of the moments of FITC-dex and CoQ1H2 concentration versus 
time outflow curves 
 
For a given concentration versus time outflow curve, C(t), following the bolus 
injection of FITC-dex or CoQ1H2, the mean transit time ( t ), the variance (σ2), and the 
third central moment (skewness; m3) can be calculated using Equation (4.1). 
 
t =
tC(t) dt
0
∞
C(t) dt
0
∞
; σ2 =
t – t
2 C(t) dt
0
∞
C(t) dt
0
∞
; m3 =
t – t
3 C(t) dt
0
∞
C(t) dt
0
∞
        (4.1) 
 
To minimize the effect of noise in the tails of the FITC-dex and CoQ1H2 
concentration versus time outflow curves (Figure 3.2) on the estimated values of
 
t , σ2 
and m3, we utilize a model-based approach to estimate these moments as an alternative to 
Equation (4.1) (Audi et al. 2003; Audi et al. 1998; Audi et al. 1995). Thus, for a given 
C(t), t , σ2 and m3 were obtained by fitting a shifted random walk function (SRWF) to 
C(t). SRWF is a probability density function whose functional form is defined by 
Equation (4.2)             
 
                           0                                                                   , for t ≤ ts 
                          
 
                                        
  θ"4π
t  t%θ exp )" *1 
t  t%θ +4 t  t%θ , 
                                                                                     
, for t > ts          (4.2) 
SRWF(t)  = 
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SRWF(t) has the property that,
 
	 SRWF(t)∞
0
=1. The SRWF(t) parameters θ, φ and ts are 
related to t , σ2 and m3 by the following equations (Audi et al. 1996): 
 
        t  θ 1  2"  t% 
 
                                                      σ  . 2"  8
"  2 . 
t  t% 
         
 m  .12"  64.". . .θ. 
 
 
 The fitting procedure consists of finding the values of θ, φ and ts for which 
Equation (4.2), scaled by the inverse of the flow (F), best fits C(t) in the least-squares 
sense. The nonlinear parameter optimization procedure was carried out using the 
MATLAB 7.0.1 subroutine ‘lsqcurvefit’, which solves a non-linear curve fitting problem 
in the least-squares sense (The MathWorks, Inc.) using the Levenberg-Marquardt 
algorithm. Figure 4.1 shows examples of the SRWF fits to FITC-dex and CoQ1H2 
concentration versus time outflow curves from a normoxic and a hyperoxic lung. For 
both normoxic and hyperoxic lungs, the Coefficient of Variation (CV), which is a 
normalized measure of the goodness of fit of the SRWF to the concentration versus time 
outflow curves, was ~12.2 % for FITC-dex and ~12.6 % for CoQ1H2.  
 
 
 
  (4.3a) 
(4.3b) 
(4.3c) 
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Figure 4.1: Venous effluent FITC-dex and CoQ1H2 normalized concentration (as a 
fraction of the injected amount per milliliter of effluent perfusate) vs. time data following 
the bolus injection of the indicators upstream from the pulmonary artery of a normoxic 
(panel a.) and a hyperoxic (panel b.) lung perfused with perfusate containing different % 
BSA concentrations. Solid lines are SRWF fits.  
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4.2 Evaluation of the assumption of rapidly equilibrating interactions of CoQ1H2 
with plasma albumin (BSA) and with lung tissue 
 
The CoQ1H2 apparent extravascular mean residence time ( t e) at a given perfusate 
BSA concentration was determined by subtracting the mean transit time of the FITC-dex 
outflow curve (CR(t)) from that of the CoQ1H2 outflow curve (CF(t)) measured with the 
lung connected to the ventilation-perfusion system (Figure 3.2), i.e., 
 
t e = t F – t R     (4.4) 
 
 
where t R and t F are the mean transit times of CR(t) and CF(t), respectively, and their 
values were determined as described above.  
Audi et al. considered the relationship between the apparent extravascular mean 
residence time ( t e) and perfusate albumin concentration [BSA] for a flow-limited 
indicator for the case in which 1) the equilibration of the free form of the indicator 
between perfusate and tissue and 2) the association-dissociation of the indicator with 
plasma protein and with lung tissue occur rapidly in comparison to the capillary mean 
transit time (Audi et al. 1994; Audi et al. 1995). They showed that 
  
1
t eF
=
1
MQ t +
1
MQ t
[BSA]
K    (4.5) 
 
where, M is the tissue-to-plasma partition coefficient of the flow-limited indicator, Qt is 
the tissue volume accessible to the flow-limited indicator from the vascular region, K is 
the indicator-BSA binding equilibrium dissociation constant, F is the perfusate flow, and 
Qe = t eF  is the apparent extravascular volume of the flow-limited indicator (Audi et al. 
1994; Audi et al. 1995).  
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With the value of K-1 for CoQ1H2 set to 3.8 per % [BSA] as previously estimated 
(Audi et al. 2008), Equation (4.5) is a one-parameter linear model with slope and 
intercept = 1/MQt. Equation (4.5) was fit separately to the mean values of 1
t eF
 versus 
[BSA]
K  for normoxic and hyperoxic lungs (Figure 4.2). 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2: Symbols are data from normoxic (n = 6) and hyperoxic (n = 5) rat lung 
experiments plotted according to Equation (4.5).  K-1 was 3.8/ % BSA (Audi et al. 2008). 
The extravascular volume Qe is the product of the extravascular mean residence time ( t e) 
and flow (F). [BSA] and K represent the concentration of BSA (%) present in the 
perfusate, and the indicator-BSA binding equilibrium dissociation constant, respectively. 
Solid lines indicate Equation (4.5) fit to data, resulting in a slope = intercept = 4.7 x 10−2 
ml−1 for normoxic lungs (r2 = 0.98) and 2.0 x 10−2 ml−1 for hyperoxic lungs (r2 = 0.85). * 
indicates values that are significantly different between normoxic and hyperoxic lungs (t-
test; p < 0.05). 
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The ability of Equation (4.5) to fit the data in Figure 4.2 reasonably well (r2  = 
0.98 and 0.85 for normoxic and hyperoxic lungs, respectively) supports the rapidly 
equilibrating assumption of CoQ1H2 with perfusate BSA and tissue in normoxic and 
hyperoxic lungs (Audi 1993; Audi et al. 1994; Audi et al. 1995).  
 Rat exposure to hyperoxia increased the apparent extravascular mean residence 
time ( t e) for CoQ1H2 at all three perfusate BSA concentrations studied (Figure 4.2). For 
instance, the value of t e at a perfusate BSA of 5% for hyperoxic lungs was ~73% larger 
than that for normoxic lungs. This increase in t e values could be due to hyperoxia-
induced increase in lung wet weight accessible to CoQ1H2 from the vascular region 
(Table 3.1) and/or hyperoxia-induced increase in CoQ1H2 tissue-to-perfusate partition 
coefficient (M). 
 
4.3 Effect of exposure to hyperoxia on lung vascular volume and vascular transit 
time distribution 
 
The lung vascular mean transit time ( t v) and variance of the vascular transit time 
distribution (σv2) were obtained by finding the difference between the mean transit times  
( t ) and variances (σ2) of the FITC-dex curves measured with the lung in place (CR(t)), 
and with the lung removed (tubing; Ctub(t)) from the perfusion system (Figure 4.3), i.e., 
  
t v = t R – t tub    (4.6) 
 
    σv
2
= σR
2
– σ tub2                (4.7) 
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Figure 4.3: Venous effluent FITC-dex normalized concentration (as a fraction of injected 
amount per milliliter of effluent perfusate) vs. time data collected with and without the 
lung connected to the ventilation perfusion system for a normoxic (panel a.) and a 
hyperoxic (panel b.) lung.  
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The lung vascular volume (Qv) was determined as the product of t v and the 
perfusate flow (F). 
     Qv = t v . F                              (4.8) 
 
The relative dispersion (RDv), which is a dimensionless measure of the 
heterogeneity of lung vascular transit time distribution, was calculated using Equation 
(4.9) 
RD v = σv2 / t v              (4.9) 
 
Table 4.1 shows that rat exposure to hyperoxia decreased t v and Qv by ~21%, 
with no significant effect on σv2 or RDv. 
 
Table 4.1: Lung vascular mean transit times, variances, relative dispersions, volumes, 
and apparent CoQ1H2 extravascular volumes 
  
 
t v, σv2, RDv and Qv are the lung vascular mean transit time, variance of vascular transit 
times, the relative dispersion of the vascular transit time distribution, and the vascular 
volume, respectively. Qe is the apparent extravascular volume for CoQ1H2 for lungs 
perfused with control perfusate (5% BSA). n = 9 (normoxic) and 5 (hyperoxic) for all 
parameters. Values are mean ± SE. * indicates values that are significantly different 
between normoxic and hyperoxic lungs (t-test; p < 0.05).  
 
 
 
 
 
t v (sec) σv2 (sec2) RDv Qv (ml) Qe (ml) 
Normoxic 
lungs 4.18 ± 0.26 4.05 ± 0.63 0.47 ± 0.02 0.70 ± 0.04 1.41 ± 0.11 
Hyperoxic 
lungs 3.29 ± 0.17*
 2.82 ± 0.52 0.50 ± 0.04 0.55 ± 0.03* 2.44 ± 0.22* 
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4.4 Effect of rat exposure to hyperoxia on lung capillary mean transit time, 
volume and transit time distribution 
 
Method A 
The approach developed by Audi et al. (referred to as method A in (Audi et al. 
1994) for estimating the moments of hc(t) is based on Equations (4.10a-b), which relate 
the moments ( t1, σ1 and m1) of hc(t) to those of the concentration versus time outflow 
curves of a vascular indicator (CR(t)) and a flow-limited indicator (CF(t)).  
 
            σ    σ  σ   2*1   34+   15 σ1          (4.10a)    
 
          m   m  m  2*1   34+   15 m1         (4.10b) 
 
where t e = t F – t R and the subscripts c, R and F represent hc(t), CR(t) and CF(t), 
respectively. Equations (4.10a-b) with three unknowns, namely, t1, σ1 and m1, represent 
an underdetermined system. Hence, estimating the values of these unknowns using 
Equations (4.10a-b) requires at least two flow-limited indicators having different t e 
values (Audi et al. 1994; Audi et al. 1995). For the present study, the outflow curves of 
CoQ1H2 at the three different perfusate BSA concentrations (Figure 4.1) represent three 
flow-limited indicators with different
 
t e values (Figure 4.2). For the purpose of 
parameter estimation, Equations (4.10 a-b) were re-written as follows (Audi et al. 1994):    
      
           σ6    σ6  σ   781   t6t1 9
   1: σ1 (4.11a) 
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     m6   m6  m  781   t6t1 9
   1: m1 
 
where i = 1,2,.., j, and j represents the number of flow-limited indicators (j = 3 for the 
data in Figure 4.1), each with a different extravascular mean residence time t ei. The 
moments of hc(t) are then estimated using nonlinear least squares approximation using 
the above equations in the following forms (Audi et al. 1994; Audi et al. 1995): 
 
           F;t ei, σei2 , t c, σc2=   >?2*1  t eit c+2   15 σc2      σei2 @  σei2A  
 
       G;t ei,mei3 , t c,mc3=   >?2*1   t eit c+3   15mc3 3      mei33 @  mei33A  
 
  
The optimization routine finds the values of  t1, σ1 and m1, that minimize the term 
(4.13). 
 
   ∑ F;t ei, σei2 , t c, σc2=2   G;t ei,mei3 , t c,mc3=2jiC1  
       
 
 The lower bounds on t1, σ1 and m1 were set at zero. The vascular skewness mR3  
was set as the upper bound on m1. The upper bounds on σ1 and t1 were σ1DEF  
(Equation 4.14a) and t1DEF, (Equation 4.14b), respectively. 
 
 
(4.12a) 
(4.12b) 
(4.13) 
 (4.11b) 
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σ1DEF  σ61  m6m 
 G  1 
 
t1DEF  t6?.1  σ6σ1DEF .  1
  
 
 
 The values of  t1, σ1 and m1, estimated from the moments of the FITC-dex and 
CoQ1H2 outflow curves using Method A are given in Table 4.2, which shows that 
exposure to hyperoxia increased RDc by ~31%, with no significant effect on t c, σ1 
or m1. The estimated values of t c ranged between 1.14 sec and 2.49 sec for normoxic 
lungs, and 0.74 sec and 1.8 sec for hyperoxic lungs. The estimated values of σ1 ranged 
between 0.97 sec2 and 3.38 sec2 for normoxic lungs, and 0.66 sec2 and 3.75 sec2 for 
hyperoxic lungs. This wide range in the estimated values of t c and σ1  for the normoxic 
and hyperoxic lungs is due to the high correlation between t c and σ1  in Equation 4.13. 
This correlation was revealed by fixing t c at 50 % above or below the estimated value of 
t c for one normoxic lung and then estimating the values of σ1 and m1 using Equation 
4.13. This reduced the number of unknown parameters in Equation 4.13 from three to 
two. Table 4.3 shows that the sum of squared errors (SSE) between Equation 4.13 fit and 
the data was not significantly affected (F-test) by fixing the value of t c over a wide range 
(Motulsky and Ransnas 1987). The SSE is the sum of the squares of the deviation of 
every point in the fit from its corresponding point in the original data. 
(4.14a) 
(4.14b) 
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Table 4.2: Lung capillary mean transit times, variances, skewnesses, relative dispersions 
and volumes estimated using Method A 
 
 t c (sec) σc2 (sec2)  m1 (sec3) RDc 
Normoxic 
lungs 
(n = 9) 
1.55 ± 0.18 1.72 ± 0.31 4.44 ± 1.22 0.84 ± 0.02 
Hyperoxic 
lungs 
(n = 5) 
1.33 ± 0.22 2.35 ± 0.65 9.36 ± 3.27 1.10 ± 0.02* 
 
t c, σc2, m1, and RDc are the pulmonary capillary mean transit time, variance of capillary 
transit times, skewness of capillary transit times, and relative dispersion of the capillary 
transit time distribution, respectively. Values were estimated using Equations (4.12a-b). 
Values are mean ± SE. * indicates values that are significantly different between 
normoxic (n = 9) and hyperoxic (n = 5) lungs (t-test; p < 0.05). 
 
 
Table 4.3: Effect of fixing the value of   t1 on the estimated values of σ1, m1, and the 
goodness of Equation 4.13 with two parameters to data  
 
  t1 (sec) σ1 (sec2)  m1 (sec3) RDc SSE 
 
Estimated value of  t1  
 
1.14 0.97 1.95 0.87 0.0074 
  t1 fixed at 50% of 
its estimated value 
 
0.57 0.27 0.29 0.92 0.0088 
  t1 fixed at 150% of 
its estimated value 
 
1.71 1.98 5.53 0.82 0.0084 
  t1, σ1, m1, RDc and SSE are the pulmonary capillary mean transit time, variance of 
capillary transit times, skewness of capillary transit times, relative dispersion of the 
capillary transit time distribution and the sum of squared errors between Equation 4.13 fit 
and data. Values were estimated using Equations (4.12a-b).  
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In order to better understand the basis for the high correlation between parameters 
estimated using Method A, we carried out a sensitivity analysis. Sensitivity functions are 
used to evaluate the sensitivity of a given set of data to a given parameter and the ability 
of a given set of data to separately identify multiple parameters (Bassingthwaighte and 
Chaloupka 1984). Two parameters are said be dependent or highly correlated if their 
sensitivity functions are identical or algebraically related. Based on Equation (4.10 a-b), 
the sensitivities of σe2 to t c and σc2 are given by Equations (4.15 a-b). 
                        ∂σ∂t1   2 σ1 1  tt1  tt1 
 
IJKLIJML   NO  PKPML   OQ 
Previously, Audi et al. (Audi et al. 2003) estimated values of 2.8 sec and 0.9 for 
the capillary mean transit time and relative dispersion of the capillary transit time 
distribution in the isolated perfused normoxic rat lung. Assuming these values for t c and 
RDc, Equations (4.15a-b) were evaluated for t e values ranging from 1 to 100 seconds. 
The ratio of the sensitivity functions of  σe2 to t c and σc2 (Equations (4.15 a-b)) was then 
plotted as a function of t e/ t c (Figure 4.4). For t e/ t c> 3, the ratio of the sensitivity 
functions for t c and σc2 appears to be virtually independent of the value of t e. Hence, for 
t e/ t c> 3 the values of σe2 at different t e values are not sufficient to separately identify t c 
and σc2. For the data exemplified in Figure 4.1, the values of t e ranged between 5 and 12 
sec for normoxic lungs and 11 and 35 sec for hyperoxic lungs. For a t c value of 2.5 sec, 
the t e/ t c ratio at perfusate BSA concentrations of 10, 5 and 3% are ~2, 4 and 6 for 
(4.15a) 
(4.15b) 
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normoxic lungs and 4, 6 and 12 for hyperoxic lungs, respectively. Even for normoxic 
lungs, the range of t e values is close to that where the correlation between t c and σc2 
would be expected to be relatively high. Thus, to be able to use method A to evaluate the 
effect of hyperoxia on lung capillary volume and transit time distribution, one would 
need to identify at least two flow-limited indicators with t e values that are not only 
different, but are also small enough relative to t c to break the correlation between t c and 
σc
2
.  
Figure 4.4: Ratio of the sensitivity functions (Equations (4.15 a-b)) of σe2 to t c and 
σc
2
  plotted as a function of t e/ t c. The values of t c and RDc used were 2.8 sec and 
0.9, respectively. 
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Method B1 
Previous studies have demonstrated that > 90% of the variance of the lung 
vascular transit time distribution in the dog lung lobe, rabbit lung and rat lung was due to 
the capillary bed (Ahuja 2007; Audi et al. 2003; Audi et al. 1994; Audi et al. 1995; 
Clough et al. 1998). Thus, one approach for breaking the correlation between t c and σc2  
in Equation (4.10a) would be to set the value of σc2 to σv2 , which is the variance of the 
lung vascular transit time distribution (Table 4.1). This approach is referred to as Method 
B1 in (Audi et al. 1994). Under this assumption, algebraic manipulation of Equation 
(4.10a) leads to the following relationship between t c and the extravascular moments of a 
flow-limited indicator outflow curve (CF(t)) (Audi et al. 1994; Audi et al. 1995).  
 
t c =
t e
1 +
σe
2
σv
2 – 1
 
 
 
where  σe2 = σF2 – σR2 . Thus, the moments of one flow-limited indicator would be 
sufficient to determine t c using Equation (4.16). 
Model simulations (see Discussion section) revealed that if 10% of σv2   occurred 
outside the capillary bed (i.e., in the conducting vessels), the estimated value of t c using 
Equation (4.16) would be overestimated by ~7%. Thus, we used Equation (4.16) to 
estimate t c under the assumption that σc2 is equal to σv2 . 
Table 4.4 shows the values of t c estimated from the moments of CoQ1H2 outflow 
curves measured at the three different perfusate BSA concentrations. For both normoxic 
and hyperoxic lungs, perfusate BSA concentration had no effect on the estimated values 
(4.16) 
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of t c using Equation (4.16). However, for all three perfusate BSA concentrations studied, 
the estimated values of t c for hyperoxic lungs were ~42% lower as compared to those for 
normoxic lungs (Table 4.4). Furthermore, the estimated values of the capillary relative 
dispersion RDc were ~40% higher for hyperoxic lungs as compared to normoxic lungs. 
The capillary volume as a fraction of the total lung volume was ~60% and ~40% in 
normoxic and hyperoxic lungs, respectively.  
Table 4.4: Estimated values of the capillary mean transit time and relative dispersion as a 
function of perfusate BSA concentration for normoxic and hyperoxic lungs 
 
 3% BSA 5% BSA 10% BSA 
 
t c  
(sec) 
RDc  
 
t c  
(sec) 
RDc  
 
t c  
(sec) 
RDc  
Normoxic 
 
2.45 ± 
0.37 
0.82 ± 
0.05 
2.44 ± 
0.33 
0.78 ± 
0.03 
2.59 ± 
0.29 
0.77 ± 
0.02 
Hyperoxic  1.45 ± 
0.15* 
1.14 ± 
0.01* 
1.44 ± 
0.16* 
1.15 ± 
0.02* 
1.41 ± 
0.15* 
1.17 ± 
0.03* 
 
t c and RDc are the pulmonary capillary mean transit time and relative dispersion of the 
capillary transit time distribution, respectively. Values are mean ± SE, n = 6 and 5 for 
normoxic and hyperoxic lungs, respectively. * indicates values that are significantly 
different between normoxic and hyperoxic lungs (t-test; p < 0.05).  
 
One way to evaluate the assumption that the variance of the total vascular transit 
time distribution (σv2 ) is due to the capillary bed, would be to rearrange Equation (4.16). 
This results in Equation (4.17), which suggests the following relationship between t e and  
σe
2
  with one unknown parameter, namely t c. 
    
 σ  σRt1 t  2 σRt1 t 
                                                   
(4.17) 
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 The ability of Equation (4.17) to fit the σe2  versus t e data (Figure 4.5) for the 
normoxic and hyperoxic bolus injection data exemplified in Figure 4.1 is consistent with 
the above assumption. Table 4.5 shows that the values of t c estimated using Equation 
(4.17) for normoxic and hyperoxic lungs are virtually the same as those in Table 4.4 
estimated using Equation (4.16). So t c could be estimated using either Equation (4.16) or 
Equation (4.17). 
 
Table 4.5: Values of capillary mean transit time, variance, relative dispersion and 
volume in normoxic and hyperoxic lungs estimated using Method B1 
 
 t c (sec) σc2 (sec2) RDc Qc (ml) Qc /Qv 
Normoxic 
lungs 
 
2.45 ± 0.26 4.05 ± 0.63 0.82 ± 0.03 0.41 ± 0.04 0.58 ± 0.04 
Hyperoxic 
lungs 
 
1.43 ± 0.15* 2.82 ± 0.52 1.15 ± 0.01* 0.24 ± 0.03* 0.43 ± 0.04* 
 
t c, σc2, RDc and Qc  are the pulmonary capillary mean transit time, variance of capillary 
transit times, relative dispersion of the capillary transit time distribution and the capillary 
volume, respectively. Qv is the lung vascular volume. t c values were estimated using 
Equation (4.17). Values are mean ± SE. * indicates values that are significantly different 
between normoxic (n = 9) and hyperoxic (n = 5) lungs (t-test; p < 0.05). 
 
47 
 
   
0 4 8 12 16 20 24
0
150
300
450
600
750
Normoxic lung
Hyperoxic lung
Equation (4.6) fit
t e (sec )
σe
2 (sec2)
 
Figure 4.5: Symbols are data from the outflow curves shown in Figure (4.1) plotted 
according to Equation (4.17). t e and σe2  are CoQ1H2 extravascular mean residence time 
and variance, respectively. Solid lines are Equation (4.17) fit to the normoxic (r2 = 0.99) 
and hyperoxic (r2 = 0.98) data. The estimated value for t c was ~2.45 and ~1.43 for 
normoxic and hyperoxic lungs respectively. 
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A random walk function (Equation (4.2)) was used to approximate the functional 
shape of the capillary transit time distribution for normoxic and hyperoxic lungs (Figure 
4.6) using the average of the estimated values of the capillary mean transit times and 
variances in Table 4.5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6: Functional form of the capillary transit time distribution for normoxic and 
hyperoxic lungs approximated using a shifted random walk function (Equation (4.2)) 
with the shift (ts) set to zero. 
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5. SUMMARY, DISCUSSION AND CONCLUSIONS 
 
 
 The objective of this study was to evaluate the effect of rat exposure to hyperoxia 
(85% O2 for 7 days) on the capillary mean transit time, t c, and the capillary transit time 
distribution, hc(t), in the intact rat lung using the multiple indicator dilution method 
developed by Audi et al. (Equations (4.11 a-b)) (Audi et al. 1994; Audi et al. 1995). The 
results demonstrate the utility of this method for determining hc(t), with CoQ1H2 as the 
flow-limited indicator, under the assumption that all of the variance of the lung vascular 
dispersion is due to the capillary bed. Moreover, the results suggest that rat exposure to 
this hyperoxia model decreases lung capillary mean transit time by ~42% and increases 
the heterogeneity of hc(t) by ~40%. In what follows, we discuss the results of this study, 
the limitations of the method, and draw some conclusions. 
 The method developed by Audi et al. for estimating hc(t) in the intact lung, 
referred to as Method A (Equations 4.11 a-b), requires the bolus injection of a vascular 
indicator and two rapidly equilibrating (or flow-limited) indicators with sufficiently 
different extravascular mean residence times ( t e). Initial application of Method A, with 
CoQ1H2 at different perfusate BSA concentrations as the flow-limited indicators (Figure 
4.1), revealed high correlation between σc2 and t c. In other words, different combinations 
of σc2 and t c values gave similar fits (Table 4.3) based on Equations (4.12 a-b). To 
determine the reason for this high correlation, we carried out sensitivity analysis (Figure 
4.4), which revealed that the two flow-limited indicators needed for applying method A 
should have t e values that are not only sufficiently different, but also small enough 
relative to t c, such that t e/ t c is < 3 to break the correlation between t c and σc2 in 
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Equations (4.11 a-b). For the present study, the values of  t e for CoQ1H2 at the three 
different perfusate BSA concentrations studied appear to be too high relative to t c, 
especially for hyperoxic lungs, to be able to separately identify σc2 and t c based on 
Equations (4.11a). Previous applications of Method A in isolated perfused dog lung 
lobes, rabbit lungs and rat lungs done by Audi et al. utilized the lipophilic test indicators 
diazepam and alfentanil, or diazepam at different perfusate albumin concentrations as the 
flow-limited indicators (Audi et al. 1994; Audi et al. 1995). For those studies, the values 
of t e/ t c ranged between 1 and 4 for the dog lung lobes, 1 and 3 for the rabbit lungs, and 
1 and 2 for the normoxic rat lungs. 
 Previous studies in various species including normoxic rat lungs have suggested 
that > 90% of the variance of the lung vascular dispersion is due to the capillary bed 
(Audi et al. 2003; Audi et al. 1994; Audi et al. 1995; Clough et al. 1998). Thus, as an 
alternative to Method A, we utilized Method B1 (Audi et al. 1994; Audi et al. 1995) to 
evaluate the effect of rat exposure to hyperoxia on lung hc(t). Method B1, which is a 
simplified version of Method A, assumes that all the variance of the lung vascular 
dispersion is due to the capillary bed (Audi et al. 1994; Audi et al. 1995). Under this 
assumption, σc2 is fixed to σV2 , which is the difference between the variances of the 
outflow curves measured following bolus injections of FITC-dex with and without the 
lung connected to the perfusion system (Equation (4.7)). With σc2 known, the moments of 
the outflow curve of one flow-limited indicator (CoQ1H2) would be sufficient to estimate 
t c using Equation (4.16).  
Table 5.1 summarizes previous estimates of the pulmonary capillary mean transit 
time ( t c) capillary volume (Qc = F. t c), and relative dispersion (RDc) of hc(t) for the 
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normoxic rat lung for comparison with the present study. To put this comparison in 
perspective, it is useful to compare Qc, which is less dependent on the flow (F) than is t c.  
 
 
Table 5.1: Estimates of pulmonary capillary perfusion parameters for normoxic rat lungs 
in chronological order 
 
Method Body 
wt, g 
Qc, ml Qc ml/kg 
Body wt 
Flow 
ml/min 
 
t c
 
, s RDc Reference 
Morphometric 363 ± 4 
0.66 ± 
0.06 1.82    
(Crapo et al. 
1980) 
Morphometric 366 ± 4 
0.71 ± 
0.06 1.94    
(Sjostrom 
and Crapo 
1983) 
Morphometric 224 0.58 ± 0.05 2.6    
(Randell, 
Mercer, and 
Young 
1990) 
Fluorescence 
microscopy 
360 -
580 
0.49 ± 
0.03 1.04 7.5 
3.9 ± 
0.2 
0.57 ± 
0.02 
(Presson et 
al. 1997) 
Morphometric 306 ± 5 
0.51 ± 
0.05 1.67    
(Howell, 
Preston, and 
McLoughlin 
2003) 
MID 
Method A 
323 ± 
6 
0.47 ± 
0.02 1.46 30 
0.94 ± 
0.04 
0.91 ± 
0.03 
(Audi et al. 
2003) 
Present 
method 
(Method B1) 
292 ± 
9 
0.41 ± 
0.04 1.40 10 
2.45 ± 
0.24 
0.82 ± 
0.03 
Present 
study 
 
Estimates of pulmonary capillary blood volume (Qc), mean transit time ( t c), and relative 
dispersion (RDc) of hc(t). Values are mean ± SE. 
 
 
Table 5.1 shows that the capillary volume estimated in the present study is close 
to that estimated by (Audi et al. 2003) using Method A with 3H-alfentanil and 14C-
diazepam as the flow-limited indicators, and to the capillary volume estimated by 
(Presson et al. 1997) using subpleural vessel fluorescence video-microscopy under 
similar flow conditions. However, Table 5.1 shows that the morphometric estimates of 
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the capillary volume (0.58 to 0.71 ml) are higher than those estimated in the present study 
or by using subpleural vessel fluorescence video-microscopy (Crapo et al. 1980; Randell, 
Mercer, and Young 1990; Sjostrom and Crapo 1983). This is not surprising, since 
morphometric estimates of capillary volume have sometimes been considered to be close 
to the maximum value, which might not be achieved when the pulmonary blood flow and 
vascular pressures are low, as is the case in the present study (Audi et al. 1994; Audi et 
al. 1995).  
The estimated relative dispersion (RDc) of the capillary transit time distribution 
for normoxic lungs, 0.82 ± 0.03 (SE), in the present study (Table 4.2) is close to that 
estimated by (Audi et al. 2003) using method A with 3H-alfentanil and 14C-diazepam as 
the flow-limited indicators (0.91 ± 0.03), but smaller than that estimated using subpleural 
vessel fluorescence video-microscopy (0.57 ± 0.02) under similar flow conditions 
(Presson et al. 1997). This could be, in part, due to morphometric differences between 
subpleural and intrapulmonary capillary beds (Guntheroth, Luchtel, and Kawabori 1982; 
Miller 1947), although Presson et al. suggested that these differences might not be 
significant for the rat lung (Presson et al. 1997).  
 Table 4.3 shows that rat exposure to hyperoxia (85% O2 for 7 days) decreased the 
lung capillary volume by more than 40% from 0.41 ± 0.04 (SE) ml to 0.24 ± 0.03 ml.  
This result is consistent with that measured by (Crapo et al. 1980) using a morphometric 
method. They showed that rat exposure to 85% O2 for 7 days decreased the capillary 
volume by ~53% from 0.66 ± 0.06 (SE) ml to 0.31 ± 0.04 ml. This hyperoxia-induced 
decrease in capillary volume is also consistent with the hyperoxia-induced ~58% 
decrease in rate (PS) of ACE-mediated FAPGG hydrolysis measured in the present study 
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(Table 3.2). Assuming no change in ACE activity per unit surface area between normoxic 
and hyperoxic lungs, the estimated PS value (Table 3.2) would be a measure of perfused 
surface area (Audi et al. 2003; Audi et al. 2008). The ~58% hyperoxia-induced decrease 
in PS product (Table 3.2) is consistent with the ~50% decrease in surface area of the 
capillary endothelium measured by Crapo et al. using morphometric methods (4524 ± 
324 (SE) cm2  vs. 2289 ± 269 cm2) (Crapo et al. 1980).  
 The results of the present study suggest that rat exposure to hyperoxia not only 
decreased the capillary volume, but also increased the relative dispersion of hc(t) by 
~40% from 0.82 ± 0.03 (SE) to 1.15 ± 0.01 for normoxic and hyperoxic lungs, 
respectively. To our knowledge, this is the first study to evaluate the effect of rat 
exposure to 85% O2 for 7 days on the heterogeneity of hc(t). This hyperoxia-induced 
increase in the RDc is revealed in the measured CoQ1H2 and FITC-dex outflow curves 
(Figures 3.2) as a decrease in the shift of the peaks of CoQ1H2 relative to that for the 
FITC-dex curve as demonstrated by model simulations described next. 
To evaluate the effect of an increase in the heterogeneity of hc(t) on the extent of 
shift between the peaks of the outflow curves of a vascular indicator and a flow-limited 
indicator, two lung models (Appendix B) were created to simulate the outflow curves of 
the vascular and flow-limited indicators following their arterial bolus injections in a 
normoxic lung (normoxic model) and a hyperoxic lung (hyperoxic model). For the 
normoxic model, the values of t c and RDc were set at 2.5 sec and 0.8, respectively. For 
the hyperoxic model, the value of RDc was set 1.2, while the value of t c was set as that 
for the normoxic model (2.5 sec). For both models, the values of t e for the flow-limited 
indicators were set at 4, 8 and 12 sec. Moreover, both models were assumed to have the 
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same level of bolus dispersion outside the capillary bed (tubing and conducting vessels). 
Figure 5.1 shows the simulated outflow curves of vascular and flow-limited indicators 
from the normoxic model (panel a.) and hyperoxic model (panel b.).  
 
 
 
 
 
 
 
 
 
 
 
        t  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1: Simulations (see Appendix B) of arterial bolus injections of a vascular 
indicator (CR(t)) and three flow-limited (CF(t)) indicators with different extravascular 
mean residence times ( t e) in a normoxic (panel a.) and a hyperoxic (panel b.) lung. The 
normoxic and hyperoxic model simulations are assumed to have the same bolus 
dispersion outside the capillary bed, same capillary mean transit time, but different 
capillary relative dispersions (RDc = 0.8 and 1.2 for normoxic and hyperoxic lungs 
simulations, respectively).   
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Figure 5.1 shows that all else being equal, increasing the heterogeneity of hc(t) 
decreases the shift between the peaks of the outflow curves of the vascular indicator and 
flow-limited indicators. 
 The simulated concentration versus time outflow curves shown in Figure 5.1 
(panel a.) were also used to evaluate the effect of vascular dispersion outside the capillary 
bed on the estimated value of t c using Method B1 (Equation (4.16)) which assumes that 
the variance of the lung vascular dispersion is due to the capillary bed. The moments of 
each of the simulated outflow curves were estimated and Equation (4.16) was then used 
to estimate t c with σV2  set at the actual value of σc2, at 1.1 times the actual value of σc2 
(10% overestimation of σc2), and at 1.2 times the actual value of σc2 (20% overestimation 
of σc2).  Figure 5.2 shows the ratios of estimated (Equation (4.16)) to actual values of t c 
as a function of σv2  / σc2. Overestimation of σc2 by 10%  and 20% resulted on average in 
overestimation of  t c by ~ 7% and ~15%, respectively.  
Table 4.1 shows the estimated values of the vascular volume and vascular relative 
dispersion in normoxic and hyperoxic lungs. The estimated vascular volume of 0.70 ± 
0.04 ml in the present study is similar to that estimated previously (0.75 ± 0.05 (SE) ml) 
under similar flow conditions (10 ml/min) (Audi et al. 2005), but about 17% lower than 
that estimated (0.85 ± 0.06 (SE) ml) at a flow of 30 ml/min (Audi et al. 2003). To 
determine whether passive distension of blood vessels resulting from the higher perfusion 
pressure (~10 Torr) at 30 ml/min compared to a perfusion pressure of ~5 Torr at 10 
ml/min could account for this difference in vascular volume, we carried out the following 
analysis.  
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Figure 5.2: Ratio of estimated value (Estimated) of capillary mean transit time ( t c) using 
Equation (4.17) to that used in the simulations (Simulated) as a function of the ratio of 
total vascular variance (σv2 ) to the capillary variance (σc2 ) for three different 
extravascular mean residence times ( t e). The values of t c and σc2  used in the model 
simulations were 2.5 sec and 4 sec2, respectively. The values of extravascular mean 
residence times ( t e) were 4.0, 8.0, and 12.0 sec. 
 
 
Let us start by assuming a linear relationship between vessel diameter (D), 
transpulmonary pressure (Pt) and distensibility coefficient (α). 
 
    D2 = D1 (1 + α (Pt2 – Pt1))    (5.1) 
 
where D1 and D2 are the vessel diameters at pressures Pt1 and Pt2, respectively (Ahuja 
2007). Assuming the value of P to be the average of the arterial and venous pressures (~0 
Torr), a constant α of 2.8 % per Torr and a cylindrical model for arteries, capillaries and 
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veins (Karau et al. 2001), Equation (5.1) predicts an 8.0 % increase in diameter due to a 
2.5 Torr increase in pressure. This increase in diameter would translate to ~17 % increase 
in volume which is equal to the ~17 % increase in vascular volume. Recent unpublished 
data from Dr. Molthen’s lab (Zablocki VA Medical Center, Milwaukee, WI) revealed no 
significant difference in α between normoxic (2.70 %) and hyperoxic (2.67 %) rat lungs. 
Thus, virtually all of the difference in the measured total vascular volume at 10 and 30 
ml/min could be accounted for by passive distension of the blood vessels.  
 Rat exposure to hyperoxia decreased lung vascular volume by ~21%, with no 
significant effect on the relative dispersion of lung vascular transit time distribution 
(Table 4.1). This decrease in vascular volume is revealed experimentally by a decrease in 
the peak of the FITC-dex outflow curve measured following the bolus injection of FITC-
dex with the lung connected to the perfusion system (Figure 3.2). This hyperoxia-induced 
decrease in vascular volume (~0.15 ml) (Table 4.1) is comparable to the hyperoxia-
induced decrease in capillary volume (~0.17 ml) (Table 4.5), which suggests that 
exposure to hyperoxia had no significant effect on the volume of the conducting vessels 
of the lung. As a result, the capillary volume as a percentage of the vascular volume 
decreased from 58 ± 4 (SE) % in normoxic lungs to 43 ± 4 % in hyperoxic lungs. 
Method B1 is equivalent to the superposition method developed by (Goresky 
1963) as implemented by (Audi et al. 1995). Thus, one would expect the estimates of  t c 
using the Goresky superposition method to be comparable to those estimated using 
Method B1, if the dispersion due to the tubing, injection, and sampling systems were 
removed from the FITC-dex and CoQ1H2 outflow curves measured in presence of the 
lung before applying the superposition method (Audi et al. 1995). Thus, application of 
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the superposition method would require deconvolution of the FITC-dex curve measured 
with the lung removed from the perfusion system from the CoQ1H2 and FITC-dex curves 
measured with the lung connected to the perfusion system (Figure 4.3). 
The use of high CoQ1H2 concentration (1200 µM) in the present study was to 
increase the signal-to-noise ratio in the tails of the measured venous effluent 
concentration versus time outflow curves following the arterial bolus injection of CoQ1H2 
(Figure 3.2). One of the underlying assumptions of this study and Equation (4.5) is that 
CoQ1H2 binding to perfusate BSA is not saturable, and hence, follows first order kinetics 
(Audi et al. 2008). The results in Figure 4.2 are consistent with this assumption. To 
further evaluate this assumption, in one normoxic lung perfused with 3% BSA perfusate, 
we measured the CoQ1H2 venous effluent outflow curves following the arterial injection 
of two boluses, one containing 800 µM CoQ1H2 and another containing 1200 µM 
CoQ1H2. Figure 5.3 shows that the normalized CoQ1H2 concentration versus time 
outflow curves for the 800 µM and 1200 µM bolus injections are virtually 
superimposable, which is consistent with the assumption that CoQ1H2 binding to BSA is 
not saturable. 
Comparison of the results from the present study with previous results using 
Method A in the isolated perfused dog lung lobe and rabbit lungs reveals quantitative 
differences in the estimated vascular and capillary mean transit times among these 
species (Audi et al. 1994; Audi et al. 1995). Assuming a normal cardiac output of 2.9 
liter/min for a 20-kg dog, Audi et al. estimated that the pulmonary capillary and the total 
pulmonary vascular mean transit times would be ~1.62 and 3.4 sec, respectively (Audi et 
al. 1994). 
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Figure 5.3: Normalized concentration versus time outflow curves obtained following 
arterial bolus injections of FITC-dex and CoQ1H2 at concentrations of 800 µM and 1200 
µM in a normoxic rat lung. 
 
For a 2.7 kg rabbit with a normal cardiac output of 340 ml/min, the estimated pulmonary 
capillary and the total pulmonary vascular mean transit times by Audi et al. are ~0.76 and 
1.7 sec, respectively (Audi et al. 1995). Assuming a normal cardiac output of 75 ml/min 
for a 300 g rat (Presson et al. 1997), the estimated pulmonary capillary and the total 
pulmonary vascular mean transit times in the present study based on the results in Tables 
4.4 would be 0.34 and 0.57 sec, respectively, without accounting for the effect of passive 
distension of blood vessels at higher flow. These values appear to be substantially shorter 
than those for the rabbit, which in turn are substantially shorter than those for the dog. 
However, the pulmonary capillary mean transit time as a percentage of the total vascular 
mean transit time appears to be similar for dogs (48%), rabbits (44%) and rats (60%). 
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Figure 5.4 shows a linear relationship between total vascular mean transit time and 
capillary mean transit times for dog, rabbit and rat lungs. Thus, the shorter capillary mean 
transit time in the rat as compared to those for the rabbit and dog may be primarily 
attributed to proportionately shorter total vascular mean transit times. Moreover, studies 
by Staub et al. (Staub and Schultz 1968) and  Mercer et al. (Mercer and Crapo 1987) 
show that the capillary length in rat lungs (~ 205 µm) was significantly shorter than in 
rabbit lungs (550-650 µm) and dog lungs (600-800 µm). 
The rat lung capillary mean transit time reported in the present study is plasma 
mean transit time, which is generally longer than that of red blood cells because of the 
Fahraeus effect (Albrecht et al. 1979; Presson et al. 1997). Presson et al. found the 
plasma mean transit time in subpleural capillaries of dog lungs to be ~40% longer than 
that for RBC (Presson et al. 1995). Assuming similar capillary velocities and diameters 
for capillaries in the rat lung, the estimated RBC mean transit time based on the results of 
the present study would be ~0.24 sec, which is close to the ~0.25 sec time needed for O2 
to diffuse and react with RBCs (Presson et al. 1997). This suggests that rat lungs have no 
reserve capillary RBC mean transit time as compared to dogs (1.2 sec) and rabbits (0.6 
sec). This could be in part due to the fact that the estimated plasma capillary mean transit 
time in the present study does not account for capillary distension due to difference in 
lung perfusion pressure at normal cardiac output (~75 ml/min for 300 g rat) as compared 
to 10 ml/min perfusate flow used in the present study. Another reason for this small 
capillary RBC mean transit time reserve for rats as compared to dogs could be the 
relatively short lung capillary length and resting capillary mean transit time for rats as 
compared to dogs (Mercer and Crapo 1987; Staub and Schultz 1968). The apparent low 
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reserve lung RBC capillary mean transit time for rats is also consistent with the fact that 
small species like rats, which have relatively high resting metabolic rates, can only 
increase their O2 consumption by 3-fold as compared to 25-fold for dogs (Presson et al. 
1997).   
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4: Lung capillary mean transit time ( t c) plotted as a function of the total lung 
vascular mean transit time ( t v) in dog, rabbit and rat. Solid line represents a linear 
regression fit (with zero intercept) to the data (r2 = 0.99). 
 
Previous studies have shown that rat exposure to 85% O2 for 7 days confers 
tolerance to the otherwise lethal effects of exposure to > 95% O2 (Crapo et al. 1980; 
Sjostrom and Crapo 1983). Understanding the underlying mechanisms of rat tolerance or 
susceptibility to > 95% O2 may lead to the identification of potential therapeutic targets 
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for protection from O2 toxicity. Additional studies would be needed to determine whether 
the hyperoxia-induced decrease in capillary volume and increase in the heterogeneity 
(RDc) of hc(t) measured in the present study are important to the hyperoxia-induced 
tolerance to > 95% O2. For instance, neutrophils have been shown to play a role in the 
pathogenesis of lung O2 toxicity and neutrophil depletion has been shown to be protective 
against hyperoxic lung injury (Auten, Whorton, and Nicholas Mason 2002). The 
measured hyperoxia-induced decrease in lung capillary mean transit time and increase in 
RDc may affect the retention or margination of neutrophils on passage through the 
capillary bed (Brown et al. 1995). However, Crapo et al. showed an increase in the 
number of neutrophils in the interstitial space of lungs of rats exposed to 85% O2 for 7 
days as compared to normoxic rat lungs (Crapo et al. 1980). Analysis of the kinetics of 
neutrophil transit through the lungs of hyperoxic rats would be needed to measure the 
effect of decrease in t c and increase in RDc on neutrophil retention in the pulmonary 
capillary bed. 
Sjostrom et al. demonstrated that rats exposed to hypoxia (10 to 11% O2) for 7 
days also develop tolerance to the otherwise lethal effects of  > 95% O2 (Sjostrom and 
Crapo 1983). However, unlike exposure to 85% O2 for 7 days, which results in the loss of 
more than half of the surface area of the capillary endothelium, exposure to hypoxia has 
no significant effect on the surface area of the pulmonary capillary endothelium 
(Sjostrom and Crapo 1983). This may suggest that the decrease in lung capillary mean 
transit time in lungs of rats exposed to 85% O2 for 7 days is not important for the 
acquired tolerance to > 95% O2. The proposed method for measuring hc(t) could be used 
to evaluate the effect of rat exposure to hypoxia on the heterogeneity of hc(t). 
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 In conclusion, the results of this study demonstrate that estimates of the rat lung 
capillary transit time distribution can be obtained from the venous effluent concentration 
versus time outflow curves of a vascular indicator and one flow-limited indicator such as 
CoQ1H2, measured following the arterial bolus injection of these indicators. Furthermore, 
the results reveal that rat exposure to hyperoxia decreased the capillary mean transit time 
and increased the heterogeneity of the capillary transit time distribution. These results are 
important for subsequent evaluation of the effect of hyperoxia on the activities of pro- 
and anti-oxidant redox enzymes in the intact lung using indicator dilution methods. For 
instance, preliminary indicator dilution studies in Dr. Audi’s laboratory have 
demonstrated that rat exposure to this hyperoxia model alters the capacity of the rat lung 
to metabolize the test indicators CoQ1, DQ, DQH2 and CoQ1H2 on their passage through 
the pulmonary circulation. The hyperoxia-induced change in lung capillary perfusion 
kinematics measured in the present study can alter the redox metabolism of these test 
indicators on passage through the lung. Thus, proper interpretation of the resulting 
indicator dilution data in terms of the effect of hyperoxia on the lung activities of the 
redox enzymes (NQO1 and mitochondrial complexes I and III) with which these test 
indicators interact on passage through the lung requires accounting for the effect of 
hyperoxia on lung capillary perfusion kinematics in the mathematical model used to 
quantify this data.  
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GLOSSARY OF TERMS 
 
hc(t) capillary transit time distribution 
CR(t) concentration (1/ml) vs. time (sec) curve of the vascular 
indicator in the venous effluent at a time t following bolus 
injection at t = 0 
 
CF(t) 
 
concentration (1/ml) vs. time (sec) curve of the flow-limited 
indicator in the venous effluent at a time t following bolus 
injection at t = 0 
 
Ctub(t) 
 
concentration (1/ml) vs. time (sec) curve of the vascular 
indicator in the venous effluent at a time t, following injection 
with the lung removed from the ventilation-perfusion system 
  tS  mean transit time (the first moment) (sec) 
  
t v lung vascular mean transit time (sec) 
t c capillary mean transit time (sec) t mean transit time of the vascular indicator concentration vs. 
time outflow curve, CR(t) (sec)  
t mean transit time of the flow-limited indicator concentration 
vs. time outflow curve, CF(t) (sec) 
tTU mean transit time of the tubing concentration vs. time outflow 
curve, Ctub(t)  (sec) 
t extravascular mean residence time (sec) 
σ
2
 variance (second central moment) (sec2) 
σv
2
 variance of lung total vascular transit times (sec2) 
σ1 variance of  hc(t) (sec2) 
σ  variance of the vascular indicator concentration versus time 
outflow curve, CR(t) (sec2) 
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σ variance of the flow-limited indicator concentration versus 
time outflow curve, CF(t) (sec2) 
 
σ  σ  -  σ , extravascular variance (sec2) 
m3 skewness (third central moment) (sec3) 
m1 skewness of hc(t) (sec3) 
m  skewness of the vascular indicator concentration versus time 
outflow curve (sec3) 
m skewness of the flow-limited indicator concentration versus 
time outflow curve (sec3) 
Qv lung vascular volume (ml) 
Qc lung capillary volume (ml) 
Qt tissue volume accessible to the flow-limited indicator from the 
vascular region (ml) 
 
Qe apparent extravascular volume of CoQ1H2 (ml) 
RDV relative dispersion of the vascular transit time distribution 
RDc relative dispersion of the capillary transit time distribution 
F perfusate flow (ml/min) 
M tissue-to-plasma partition coefficient of the flow-limited 
indicator 
K indicator-BSA binding equilibrium dissociation constant 
D vessel diameter (m) 
Pt transpulmonary pressure (torr) 
α distensibility coefficient 
 
Hct 
 
circulatory blood hematocrit (%) 
 
Pa 
 
 
lung perfusion pressure (torr) 
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BSA 
 
FAPGG 
 
FITC-dex 
 
CoQ1 
 
 
CoQ1H2 
 
DQ 
 
DQH2 
 
NQO1 
 
 
Bovine Serum Albumin (%) 
 
N-[3-(2-Furyl) acryloyl]-Phe-Gly-Gly 
 
fluorescein isothiocyanate labeled dextran 
 
coenzyme Q1 (2,3-dimethoxy-5-methyl-6-[3-methyl-2-
butenyl]-1,4-benzoquinone) 
 
coenzyme Q1 hydroquinone (reduced form of CoQ1) 
 
duroquinone 
 
durohydroquinone  (reduced form of DQ) 
 
 NAD(P)H: quinone oxidoreductase 1 
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APPENDIX A 
 
PERFUSATE COMPOSITION AND COQ1H2 PREPARATION  
 
A.1. Preparation of Perfusate: 
 Listed below are the steps to prepare 300 ml of perfusate. Perfusate of a different 
volume can be prepared by scaling the individual ingredients appropriately. 
i. Prepare a bottle of de-ionized water (DH2O). 
 
ii. Take a 300 ml beaker, label it and place a stirring stick in it. Add 250 ml of DH2O 
into the beaker (250ml for every 300 ml perfusate). 
 
iii. Place the beaker on a heater on low heat with ‘stir’ set to 2. 
 
iv. For every 300 ml BSA, add the following amounts of stock and stuff to the beaker 
in the order specified below: 
 
a. Stock 
i. KCl (Potassium chloride): 1.5 ml 
ii. KH2PO4 (Potassium dihydrogen phosphate): 1.5 ml 
iii. MgSO4 (Magnesium sulphate): 1.5 ml 
iv. CaCl2 (Calcium chloride): 1.5 ml 
 
b. Other chemicals 
i. NaCl (Sodium chloride): 2.07 g 
ii. Dextrose: 0.3 ml 
iii. NaHCO3 (Sodium bicarbonate): 0.63 g 
iv. BSA (Bovine serum albumin): 9g, 15g or 30g to obtain perfusate 
with BSA concentrations of 3%, 5% and 10% respectively 
 
v. Cover the beaker with parafilm to prevent contamination. 
 
vi. Keep stirring the mixture till all the BSA is dissolved and you are left with a 
homogenous solution. 
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vii. Pour the contents of the beaker into a graduated cylinder to ensure proper volume 
and empty the solution into a clean saline bottle. Label the bottle with date and 
contents. 
 
viii. Place the bottle in a warm water bath (37O C) for 10 minutes. 
 
ix. Bubble a gas composition of 21% O2, 79% N2 into the warmed perfusate for 
about 20 minutes to ‘blow off’ the CO2. Check the pH using a blood-gas analyzer. 
Stop bubbling when the pH value approaches 7.4.  
 
x. Bubble air (21% O2, 7% CO2, and 72% N2) into the warmed perfusate to 
equilibrate at a pH of 7.4.  
 
Gassing the perfusate in the last two steps may take approximately an hour. 
 
 
 
A.2. Preparation of CoQ1H2: 
Listed below are the steps for preparation of the bolus injectate of CoQ1H2 for use in 
MID experiments. 
i. Prepare CoQ1 stock by mixing the following ingredients: 
a. CoQ1: 5 mg 
b. Ethanol (20 mM): 2 ml 
 
ii. Prepare ethylene-diamine-tetra-acetic-acid (EDTA) stock by mixing the following 
ingredients: 
a. EDTA: 37 mg 
b. DH2O: 1 ml 
 
iii. Prepare CoQ1H2 stock by mixing the following ingredients: 
a. CoQ1 stock: 375 µl 
b. KBH4 (Potassium borohydride): 15 µl 
 
Allow one hour for the reaction to complete. Then add: 
c. EDTA stock 
 
Allow 30 minutes for the reaction to complete. The final stock has a 
concentration of 15.96 mM 
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iv. Prepare the final CoQ1H2 bolus injectate (0.1 ml) by mixing the following: 
a. CoQ1H2  stock: 75 µl 
b. BSA (bovine serum albumin): 925 µl 
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APPENDIX B 
 
MATHEMATICAL MODEL  
B.1. Single capillary element: 
 The model utilized for this study has been described previously (Audi 1993; Audi 
et al. 1998; Audi 1998). Briefly, each capillary element consists (Figure B1) of a 
capillary region and a surrounding extravascular region, with volumes Vc and Ve, 
respectively. The model assumes the following: 
 
1. The vascular indicator is confined to the capillary region, whereas the flow-
limited (diffusible) indicator can diffuse out of the capillary region into the 
extravascular region.  
2. Flow is restricted to the vascular region.  
3. Transport in the extravascular region is only by diffusion. Diffusion of both 
vascular and flow-limited indicators in the direction of flow is negligible as 
compared to the axial convective transport.  
4. With respect to the flow-limited indicator, diffusion equilibrium within the 
vascular and the extravascular volumes in the direction perpendicular to the 
flow direction is instantaneous.  
 
 Under these assumptions, the spatial and temporal variations in the concentrations 
of the vascular (R) and flow-limited (D) indicators in the vascular and extravascular 
regions are described by the following species balance equations: 
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∂[R]
∂t + W
∂[R]
∂x
= 0    (B1) 
 
    
∂[D]
∂t + W
Vc
Vc + Ve
∂[D]
∂x
= 0    (B2) 
 
where, W = L/ tc is the average flow velocity within the capillary region, where tc is the 
capillary transit time and x = 0 and x = L are the capillary inlet and outlet, respectively. 
R(t,x) and D(t,x) are the vascular concentrations of R and D at distance x from the 
capillary inlet (x = 0) and time t. The initial condition: at t = 0 , [R](x,t ) =  D(x,t) = 0; 
and the boundary condition: at x = 0, [R](x,t) = D(x,t) = Cin(t), where Cin(t) is the 
capillary inlet function. 
 
 
 
 
 
 
 
 
 
Figure B1: A schematic diagram of a single a capillary element model for the pulmonary 
disposition of a vascular indicator (R) and a flow-limited indicator (D).  
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B.2. Whole organ model: 
 To build a capillary bed or an organ, it is assumed that the capillary bed consists 
of Nx parallel, non-interacting capillary elements, each possessing a different transit time 
tci (Figure B2). These capillary elements differ only in their geometries (i.e., lengths), or 
flows or combination thereof. However, the per-unit capillary vascular volume, exchange 
surface area, and physical and chemical properties are the same for all capillary elements. 
Thus, the capillary bed has a distribution of vascular transit times, hc(t).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure B2: Nx parallel pathways corresponding to the Nx capillaries with different 
transit times tci, i = 1,…, Nx. Cin(t) is the capillary input function. [R]i and [D]i are the 
concentrations of the vascular and flow-limited indicators at the outflow of the ith 
capillary element. 
 
The organ model assumes random coupling conditions between the conducting 
vessels and the exchange vessels, i.e., all capillary elements are exposed to the same 
capillary input Cin(t). Given the linearity, commutativity, and associativity of the model, 
Cin(t) could be thought of as the outlet concentration curve that would exist if all arteries 
and veins were connected directly at a common nexus with no intervening capillaries. 
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Thus Cin(t) would include dispersion from the conducting vessels (i.e., arteries and 
veins), dispersion as a consequence of any tubing connections involved in the sampling 
or perfusion system, and dispersion resulting from the injection system. Thus, Cin(t) =  
(q/F) Ctub(t) * hn(t) where q is the mass of injected indicator; F is the total flow; Ctub(t) is 
a concentration function representing the mass dispersive processes occurring outside the 
organ, including the dispersion caused by the injection system; hn(t) is the transport 
function for vascular and flow-limited indicators in the conducting vessels of the lung, 
and * is the convolution operator. 
 For given values of Vc and Ve =  F. t e, and a given hc(t) and Cin(t), each 
represented by a Shifted Random Walk function as previously described, the single 
capillary element equations (Equations (B1-2)) were solved numerically for each of the 
Nx capillaries with transit times ti, i = 1,…, Nx as shown in Figure B2. Then the capillary 
outflow concentrations for the vascular and flow-limited indicators CR(t) and CF(t) were 
obtained by summing (doing a mass balance on) the outflow concentrations, [R]i(t) and 
[D]i(t), over all Nx capillaries, each capillary outflow being weighed by its corresponding 
H i = ∆t/2 h c(t i – ∆t/2) + h c(t i + ∆t/2) ,  which is the flow-weighted fraction of 
capillaries with transit time tci, and ∆t is the transit time increment. Thus, 
 
 
    CR(t) = H i [R] i(t)Σi = 1
Nx
    (B3) 
 
 
    CD(t) = H i [D] i(t)Σi = 1
Nx
    (B4) 
